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PREFACE 
In Pharmaceutical Industry, as a result of the sharp 
rise in the production costs. Government controls and the ' 
intensification of the competitive selling in recent years, 
the need to supplement or even to break away from "accepted" 
marketing techniques has become increasingly evident. In their 
# 
efforts to promote sales, overcome competitors and to serve 
the medical profession more efficiently and economically 
pharmaceutical houses are keeping more and more emphasis on 
the tools of 'Sales Promotion'. 
As a student of Master of Business Administration, I 
thought valuable to have first hand reaction of field force 
like medical representatives of different concerns particularly 
of IDPL, regarding the sales promotion tools for, which I met to 
the marketing executives, sales manager of IDPL in Delhi, 
Marketing Research Manager and the executives in the Sales 
Promotion Department and many doctors and retailers. Through 
this, an:%ttempt has been made to arrive at some useful and 
realistic analysis of the situation. The analysis: results 
reveal that detailing is considered as one of the best technique 
for promoting the sales in the Pharmaceutical Industry. 
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INTRODUCTION 
Phatrnacy: Pharmacy i s the sc ience and ar t concerned wilA the 
c o l l e c t i o n , preparation and s tandardizat ion of drugs. I t s scop* 
inc ludes the c u l t i v a t i o n of p l a n t s tha t are used as drugs, the 
s y n t h e s i s of chemical compounds of medicinal va lue , and the 
a n a l y s i s and standardizat ion of medicinal agents . The sc ience thsWfe 
embraces a l l a v a i l a b l e knowledge of drugs with spec ia l refexsncft 
t o the mechanism of t h e i r ac t ion in the treatment of d i sease i s 
pharmacology. Obviusly t h i s broad sc ience has many subdivisioaSr 
such as tox ico logy (the study of poisons) and therapeut ics ( the 
use of drugs in the treatment of d i s e a s e ) . 
The beginnings of pharmacy are anc ien t . When e a r l y wan 
expressed a Juice from a succulent l ea f to apply to a wound, he ill 
prac t i c ing t h i s a r t , de legated to Hygiera the duty of cor^>oUQdia0 
h i s remedies. In ancient Greece the a r t of hea l ing recognised a 
separation between the dut i e s of the phys ic ian and those of tha 
Pharmacists, 
Pharmaceuticals; The World Health Organisation (WHO), def ines a ;, 
drug or pharmaceutical preparation as "any substance or mixtuza '^ 
substance manufactured, so ld , o f f ered for s a l e , o r repreoantad fo: 
use i n . . , the d iagnos i s , treatment, m i t i g a t i o n , or prevention of 
d i s ease , abnormal phys ica l s t a t e or the symptoms thereof in roan 
or animal, (and for use i n ) . . . r e s t o r i n g , correc t ing or modifying 
organic funct ions in man or animal". 
The same organi sa t ion def ines a pharmaceutical s p e c i a l i t y 
as "a simple or compound drug ready for use and placed on the 
s : ^ 
learket under a spec ia l hame o r in c h a r a c t e r i s t i c forrn". 
The modern pharmaceutical industry began in the 19th c«n.tawi^ 
witti the discovery of highly ac t ive medicianal compounds t h a t could 
most e f f i c i e n t l y be manufactured on a l a rge s c a l e . As these com-
pounds replaced herbal medicines of e a r l i e r t imes, the occurancs 
and sever i ty of such diseases as pern ic ious anemia, rheumatic 
fever, syphl is and tubersu los i s were g r ea t l y reduced. Pharmaceu-
t i c a l industry research has g rea t ly aided medical progress of th« 
66 roost valuable drugs introduced since a s p i r i n in 1899, 57 were 
discovered and then produced in i n d u s t r i a l l a b o r a t o r i e s . 
C la s s i f i ca t i on of pharmaceutical products: Drugs may be c l a s s i f i e d 
in one of the three ways: by chemical group ( e . g . a lka lo id i . e . 
narcot ine , morphine, emetine, s t rychnine, co lch ic ine , quin ine ,n ice- . 
t i ne , a t ropine , cocaine e t c . ) ; pharmacologically ( i . e . by the way 
they work in the body); and according to t h e i r use the rapeu t i ca l ly . 
Pharmacological and therapeut ic c l a s s i f i c a t i o n s show considerable 
divergence, as drugs t h a t ac t upon the body in d i f fe ren t ways may 
br ing amount the same desiresd therapeut ic r e s u l t s . Furthermore, 
c l a s s i f i c a t i o n by therapeut ic usage i s complicated by the fac t t h a t 
dtug may be used to combat' more than one ailments e . g . the antimalft* 
r i a l compound primaquine may also be employed to r e l i eve arthritis,^ 
Some fami l ia r drugs c l a s s i f i e d by therapeut ic use include a sp i r i n , 
an analgesic , o r pain k i l l e r ; benzocaine, a loca l anes the t ic 
magnesium carbonate, an antacid; charcoal , an a n t i f l a t u l e n t ; 
p e n i c i l l i n , used agains t syphl is and major o thers as germiei<tes, 
chemotherapeutic drugs, hormone, t r a n q u i l l i z e r and vitamins e t c . 
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DRUG MULTINATIONAL IN INDIA 
Operations of multinational corporations (MNCs) in the 
less developed countries have been a matter of intense debate 
during the recent past. There are protogonists of MNCs who 
feel that MNCs are a new vehicle of international cooperation. 
They argue that MNCs, with their ability to innovate technolo-
gieS/ to operate on a large scale and to exploit advantages of 
the international division of labour, alone are capable of 
utilizing the global resources most efficiently. Antagonists 
of MNCs, on the other hand, believe that MNCs interalia perpe-
tuate the dependence of less developed countries on the 
developed countries; hinder the development of local technologi-
cal capabilities of the host LDCs, deprive the people of their 
occupation by bringing in appropriate technologies and eJctract 
the LDCs resources for their profiterring. 
Many LDCs including India welcomed foreign capital in the 
belief that it would help ease constraints on their savings and 
supplement their local investments,technology and foreign 
exchange and enable them to import capital goods and raw materials 
necessary for accelerated economic developnent. 
The Indian drugs and pharmaceutical ipdustry is one of such 
factors where MNCs are most dominant. A government appointed 
committee, popularly known as the Hathi Committee which submitted 
its report in April,1975 studied the reasons for the hold of MNCs 
over this industry. The committee observed that at the time of 
independence, MNCs were supplying their products manufactured 
:: 4 :: 
abroad to the Indian market either through local agents or 
through their own branches. After independence, enhanced 
degree of import restriction and tariff protection, induced 
MNCs to import bulk drugs and to get them processed into 
formulations on a job work, basis by the Indian concerns, 
without direct investment in factories or employment of 
technical personnel. 
Between 1952 and 1965,the MNCs in the drug industry 
received a big impetus to'boost their turnover as 'permission 
letters' to produce 36 formulations and four bulk drugs were 
granted to 15 leading foreign units. These formulations included 
even household remedies like tonics, health salts, cough mixtures, 
eye drops, gripe waters and so on, which could have been easily 
manufactured by the Indian sectors. Apart from these 12 foreign 
and 5 Indian companies could get 'Carrying on business' (COB) 
licences for 215 formulations and 20 bulk drugs, and thereby 
regularise the excess capacities created as a result of the 
liberalisation of vlicensing policy, which followed the devalua-
tion in the Indian rupee in 1966. 
The above policies in the view of the Haathi Committee 
were mainly responsible for the foreign hold over the Indian 
drugs and pharmaceutical industry. This resulted in an outflow 
of foreign exchange amounting to about 260, million towards 
payments of dividends, royalties and technical fees during the 
period 1969 to 1973 alone. 
The Hathi Committee also highlighted the fact that the 
• • ^ • • 
MNCs in the drug industry 'usually discourages' their research 
and development staff from developing technology of their own. 
These practices made our industry permanently dependent on 
overseas expertise and technology. 
In view of the above facts, the Hathi Committee pointed 
out that the, 
"Continued presence of the highly profit motivated 
multinational sectors can but promote only the business 
interest of this sectors. Their presence in India as a 
part of their global effort to capitalize on human 
suffering in an organised manner, must therefore cease 
as early as possible". 
The majority in the committee therefore 'strongly 
recommended that the multinational units in drugs and pharma-
ceuticals should be taken over by government and managed by the 
proposed National Drug Authority. All members,however, agreed, 
that the drug industry should not be eligible to preferential 
treatment as specified in the guidelines of Foreign Exchange 
Regulation Act,1973 (FERA). The committee recommended that the 
foreign drug units should not only be directed to bring down 
their equity to 40% forthwith. The Hathi Committee consisted 
of 15 members included apart from its chairman Jai Sukh Lai Hathi, 
three other influential congress members of Parliament Yashpal 
Kapoor, Vasant Sathe and C.M.Stephen, 
The drugs and pharmaceutical industry is considered one 
of the most multinational of modern manufacturing industry with 
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the leading firms exercising great oligopolistic power. In 
1974 the top 30 multinational companies accounted for 52 per 
cent of the total world market economy pharmaceutical sales. 
The superior market performance of the drug MNCs is 
due as the Hathi Committee noted to "High pressure sales 
techniques coupled with distribution of medical samples on a 
liberal scale to the medical profession (which together with 
attractively got-up medical literature and international 
brand names of drugs appearing in advertisements in foreign 
medical journals with which top consultant in >the medical 
profession were acquainted, played their part in popularising 
the drugs of foreign companies. 
Foreign companies promote a culture of product differen-
tiation under which the same basic drug is marketed under 
different brand names. 
Formulation under different 
Drug ^ brand name 
Vit.B.complex 406 
Multi-vitamin Tabs 308 
Chlorumphenicol 155 
Vit.Bj^ 2 126 
Tetracycline 115 
Source; B.S. Ranga Rao - Indian Drug Industry - Its status 
and Perspective. 
According to one estimate drug companies in India spend 
as much as 18 percent of turnover on an average on sales 
promotion, this product differentiation leads to socially 
• • '7 • • 
wasteful expenditure, cost on which are ultimately transferred 
to the cons\amer through high prices - some foreign companies 
speind even more e.g* Pfizer spent more than 20 percent of the 
total net sales on sales promotion iri 1980-81, 
The large bulk of these formulations are of little 
additional therapeutic value. Yet standard books of Pharmaco-
logy Goodman and Gilman categorically state that : 
Many mixtures of Aspirin with Actamenophen or phenacetin 
and often with caffiene and other drugs are promoted with 
claims that they provide more analgesia. None of these claims 
withstand critical scrutiny. In most criticals, relief of pain 
by an analgesia mixture has not been superior to that of 
aspirin. 
Formulations Costs 
1. Aspirin ,2 paisa 
2. Anacin 8 paisa 
3. Avedanplus 8 paisa 
4. Aspro 10 paisa 
5. Powerin 20 paisa 
Source; Goodman and Gilman - The Pharmaceutical basis of 
Therapeutics, 5th Ed.,1982. 
The Hathi Committee,in an effort to curb the social 
wastage incurred by the sales of such irretional and spurious 
formulations recommended the phased abolition of brand names. 
In thfe New Drug Policy Statements only five drugs were 
notified whose single ingredient formulation could no longer 
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be sold under brand names, 
1. Analgin 
2. .Aspirin 
3. Chlorpromazine 
4. Ferrous sulphate 
5. Piperazine and its salts 
The notification for the same was issued on Jan.17,1981, 
almost three years after the policy decision. Hoechst, the 
manufacturer of Novelgin and Pfizer the manufacturer of Pipera-
zine went to court and the order has been stayed by the Delhi 
High Court. 
Thus a policy enforcing the use of generic names that 
would save resources spent on marketing and would render 
standardisation of pharmaceutical products easier, has only 
been hesitatingly implemented and that too, has been stayed 
by the judiciary. Moreover, on the issue that no newly 
introduced single ingredient formulation would be allowed to 
bear a brand name under the New Drug Policy, the representatives 
of the West Geirmany, Swiss, British and the American Pharmaceu-
tical companies, have in a memorandum threatened the Indian 
Government with the dire consequences if this policy is not 
withdrawn. 
Dumping of Banned Drugs; 
It is a well known that a significant number of formula-
tions which have been banned, severely restricted or discarded 
(as obsolescent) in Western markets are still being sold by the 
MNCs in India. 
• • Q • • 
Antispasmodic combinations sold in India contain amido-
pyrin/ a very toxic drug banned,the world over. Yet India 
imports amidopyrin. Another formulation for anti-diarrhoea 
Lomotil manufactured by G.D.Searle is still widely sold in 
India, although the British Medical Journal'has published 
articles since 1976 warning that the drug is highly dangerous 
for young children. Similar is the case of Dimethisterone 
which is banned in Sweden, Finland, Belgium, U.K. and U.S.A., 
but is sold freely in India. The Bangladesh government has 
recently banned the manufacture, import and sale of drugs 
produced by Ciba-Geigy like Entro-vioform, Mexaform, Hoechst 
Novalgin, Baralgan and so on which are still being freely 
sold in India. 
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INDIAN DRUG INDUSTRY - A REVIEW 
Indian drug industry consists of manufacture of Pharmaceu-
tical formulations and bulk drug. 
Since Independence,the industry has made commandable 
progress in manufacture of pharmaceuticals towards making the 
self-sufficient. During last decade, the manufacture of bulk 
drugs, specially by the wholly Indian sector has made vital 
contribution due to efforts of the technocret enterpreneurs. 
The research and development programmes taken by these units 
have made tremendous impact on the natiocal scene. 
Industry Position 
Today, there are more than 400 units engaged in the 
manufacture of pharmaceuticals in the country, out of which, 
130 units are in the organised sectors, 26 units are in foreign 
sector and the rest are in the small scale sector, 
A birds eye view of the progress of the Indian industry 
can be seen from the following statistics: 
Production 
Year 
1947 
1965-66 
1975-76 
1979-80 
1981-82 
Bulk drugs 
(Rs.crore) 
_ 
18 
130 
220 
275 
Formulations 
(Rs.crore) 
10 
150 
540 
1150 
1300 
Sources Drugs & Pharmaceuticals No.8, August,1982. 
The contribution of the wholly Indian sector (ihcluding 
public sectors)'at present is 78% of bulk dmg and 64 percent 
of formulation. 
Capital Investment; 
Total capital investment in the industry today is around 
Rs.500 crores. 
Employment; 
The industry today gives direct employment to about 1.5 
lakh persons and about 5 lakh persons are engaged in retail 
and wholesale trade in the industry. About 2 lakh persons are 
employed in the pharmaceutical ancillary industries. 
Capabilities; 
The following facts speak for the capabilities of the 
National Sector of the industry which have produced following 
bulk drugs without any undue pressure from the government. 
1. Anti-biotics ; Pencillin ' 
Streptomycin 
Tetracycline 
Oxytetracyclin 
Ampicilline 
Artioxicillin 
2. Analgesic Aspirin 
Paracetamol 
Analgin 
Oxyphenbutazone 
Phenylbutazone 
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3. Anthelmentic s 
4. 
5. 
8. 
9. 
10. 
Anti Tuberculosis 
Anti-Diabetics 
6. Sulphonamides 
7, Vitamins 
Anti-Asthamatics: 
Anti-cancer 
Anti-Bacterial 
11. Anti-Hypertens ive 
Metronidazole 
Mebendazole 
Tinidazole 
Bepheniiain 
Hydroxynophthoate 
INH, PAS 
Ethambutol 
Gl ibenclamide 
Sulphaguanidine 
Sulpl^iamethoxazole 
Ph thy l - r su lpha th iazo le 
V i t . B , 
12 V i t . B 
Vi t .C 
Vit .K 
Salbutamol 
Theophylline derivatives 
Cyc1ophosphamide 
Trimethoprine 
Propranolol 
Methyleclopa 
Reserpine 
Disease pattern in India is different from what is 
observed in western countries. Like other tropical countries. 
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India has its own problem in the field of medfcines and 
accordingly, requirements of drugs is also different from 
those of U.S.A. and Europe, 
« , 
The disease frequently observed in India are: 
Tuberculosis 
Malaria 
Amoebiasis 
Leprosy 
Bronchitis 
Asthma 
Gastro-enteritis 
Jaundice 
Diarrhoea, etc. 
Scope of Research 
There is a scope of research in the following fields: 
Development of newer anti-tubercular drugs etc. 
Development of vaccines against tropical diseases e.g. 
viral infections, leprosy etc. 
Isolation of therapeutic agents from herbal remedies 
Exploration of sea-flora 
It is necessary to give attention to develop newer anti 
cancer drugs such as alkylating agents, anti-metabolites, 
harmones etc. 
In western countries, certain important drugs are availa-
ble for the treatment of cardiac disorders. They are specitic 
Beta-blockers e.g. Methoprolol, calcium,antagonists e.g. 
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Nefidipine etc. 
Many life saving drugs anti-microbial are also available 
in other market countries. This include anti-viral e.g. 
Acylovir, Immunoglobulin e.g. Oxatomide etc. 
Proper attention should be given to develop such impor-
tant medicines in the country itself. 
New Drug Policy : 
In the statement of New Drug Policy (NDP) the following 
main objectives were underlined: 
1. To develop self-sufficiency in drug technology. 
2. To offer special incentives to firms which are engaged 
in Research and Developnent. 
3. To foster and encourage the growth of the Indian sector. 
4. . To provide other parameters to control, regulate and 
rejuvenate this industry as a whole, with particular 
reference to containing and channelising the activity 
of foreign companies in accordance with national 
objectives and priorities. 
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Indian Drugs and Pharmaceutical Ltd. 
1. History : 
Indian Drugs and Pharmaceilticals Ltd., the largest 
pharmaceutical complex operating under the full patronage o± 
theGovernment of India enjoys a proud position today in the 
field of drugs and pharmaceuticals to the Indian as well as 
overseas millions, 
IDPL complexes comprises of 10 plants in India employing 
over 12,720 people. It is the largest and the most sophisti-
cated pharmaceutical complex in Asia, Africa, Latin America 
and the Middle East. 
Besides its Rishikesh plant for antibiotics,Hyderabad 
plant for synthetic drugs and fine chemicals, Gurgaon plant 
for pharmaceutical specialistics, Madras plant for formulation 
as well ^s for surgical instruments and Muzaffarpur plant for 
the drugs and chemical intermediaries, IDPL has four subsidia-
ries in the joint sector at Lucknow in U.P.,Sangrur in Punjab, 
Jaipur in Rajasthan and Bhubneshwar in Orissa, 
IDPL began with imported know-how for "just 20 drugs. ^ In 
a decade, IDPL's Research and Development has developed 30 more, 
improved technology of many including Vit.B., B_ and folic acid, 
made by only six other countries in the world. 
IDPL is the single largest producer of 13"antibiotics and 
45 synthetics drugs in bulk on a mass scale. The range of 
pharmaceutical specialities goes beyond 150 in various dosage 
formsi 
:: 16 :: 
IDPL has a massive formulations capacity of 6650 million 
tablets, 1100 million capsules and injectibles,1000 kilo-litres 
of oral liquids, 30 tones of ointments and 450 tones of powder 
pack's to provide a larger therapeutic range in various dosage 
forms to the medical profession. 
IDPL drugs meet world standards in quality, in specific 
case even higher than pharmacopeia of some of the most developed 
countries, according to a report of the Indian Medical 
Association (I.M.A). Even the well known International and 
National Pharmaceuticals firms in India rely on IDPL bulk drugs 
to formulate their own medicines. 
IDPL is the single largest supplier of medicines to 
hospitals and public dispensaries in India. It is also meeting 
no less than one third of the medicinal requirements of our 
defence services in its range. 
IDPL also offers technology and consultancy to the 
developing countries for drugs, pharmaceuticals and chemical 
plants from project consultancy to turn key operations. 
IDPL has thus given India its own sound base for the 
developments of drug industry. Its own manufacturing capability 
to attain national self-sufficiency in drugs. 
II. Functioning : 
M/s IDPL started supplying medicines primarily to Govt. 
iHrStitutions instead of going all out for trade. Market,which 
hitherto have never been done by any company. Such was the 
impact of IDPL on these government institutions for the purchase 
• • 17 • • 
of drugs. This preferential treatment was not resorted that 
IDPL started getting preferential treatment. 
There are about 5000 big and small pharmaceutical 
companies in the country. Most of them prior to the inception 
of IDPL' were concentrating on trade sales. But with more and 
more funds with government institutions due to theexpansion 
of the health programmes, few of these companies started 
their activities in the institutional selling, with the result 
IDPL started facing competition from these companies mainly in -
the small sector and few multinationals. 
IDPL in the first 2 to 3 years only had captured a major 
share of the total institutional market, but the other companies 
also started their activities and growth rate of IDPL in 
institutional selling started declining. The reason was that 
these companies could offer cuts to the purchasing authorities 
and indulge in many other corrupt activities like rais^ ing the 
billS/ without supplying medicines. Taking supplies back from 
the institution and selling it in the market, supplying of sub-
standard drugs not only the common ones but even the life saving 
drugs. 
IDPL Achieves record Production : 
The Indian Drugs and Pharmaceuticals Ltd. (IDPL), thp 
public sector undertaking has recorded the highest ever 
production of Rs.121.45 crores and the sales of Rs.108.41 crores 
during the year 1983-84, 
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The year saw according iifhe company report an overall 
improvement mainly by absorbing the unavoldab'le increase in 
the costs of inputs arising from withdrawal of certain 
concession on excise and custom duty on drug intermediates, 
normal increase in expenditure on salaries and other inputs 
due to escalation in prices of raw materials. 
Despite this, the company was able to reduce its 
losses to Rs.21 crore against Rs.24 crores of the last year. 
The company, has also attained a major break through in 
its own research and development efforts by commencing 
production of Vitamin-6. 
Source : Drugs and Pharmaceuticals Vol.7, No.5, May,1984. 
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SALES PROMOTION 
The simplest and perhaps most dynamic definition of 
sale promotion is made up of only two words 'Promoting sales" 
In other words, any method utilized to tell customers about 
the three elements of marketing mix: 
Product - Products distinctive want satisfying 
characteristics 
Place - Its availability 
Price - How much 
In Pharmaceutical industry, there are basically two kinds 
of sales promotion viz. 
fa) Commercial sales promotion through dealers, 
(b) Direct consumer stimulation (Scientific promotion) 
The basic essential elements of drug promotion in a very 
special are dedicated to inform and to educate the masses. The 
aim of drug promotion is communication between the ethicinal 
drug houses and the doctors. 
In pharmaceutical industry almost- every leading firm is 
having a separate sales promotion department under the marketing 
division. It is thought to be regarded as one of the most 
important department for constructive efforts and creative 
selling. The variety of task delegated to it and its need for 
that it is to be clothed with ample authority and responsibility. 
Who is to train the selling force and plan their creative selling 
programmes? Who is to work Vtith the distributors and dealers and 
help them in organisational operation? Who is to help them in 
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window displays? 
Another important area to be covered 'by the sales promotion 
department is the stimulation of consxamers/prescribers. Beyond 
the scope of personal selling and regular advertising is the 
employment of premiums, contests, samples, literature, mailing 
etc. This department also plays an important role in educating 
consumer in the proper use of drugs. 
Furthermore, selling andadvertising must be coordinated. 
Advertising port-folio must b^-prepared, but they are worthless 
unless the medical representatives are taught how to use them. 
Comprehensive marketing'programme today call for the 
employment of every possible techniques for moving drugs very 
fast to the consumer. How to communicate effectively depends 
upon the creative promotional strategy adopted by different 
pharmaceutical houses such as setting up store displays,holding 
trade shows and exhibitions, using samples as premiums,packing 
of the product, price of the product, brand names etc. 
Promotional Strategy; 
This is the most vital area of marketing in pharmaceutical 
products and a company can afford to neglect it only at grave 
risks to the survival of its business. The heayiest burden for 
promotion falls on personal selling, aided by sales promotion 
and sales incentives techniques. The role of advertising is 
mostly in the nature of public relations while publicity has 
some importance regarding research oriented products. 
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Sales Promotion in Pharmaceuticals; 
Sales promotion is the nucleus of any pharmaceutical 
industry, on which the whole industry is based. Many companies 
have separate sales promotion department or product manager to 
look after the sales promotion. The sales promotion done for 
pharmaceutical depends upon the nature of the product. It 
differs from product to product and from company to company. 
There are various techniques by which this function is 
operated. Since Pharmaceuticals have two types of product; 
1. Ethical products 
2. Non-ethical products 
Sales promotion of non-ethical products are those for which 
the prescriptions of the doctor is not required and these 
products are generally advertised freely. The techniques of salesi: 
promotion is done at various levels i.e. at the retailer or at 
the stockist level. These products are generally promoted through 
advertising. 
(a) By Press Advertising 
(b) Advertising on Radio or T.V, 
(c) Window display at chemists shop 
(d) Hoarding at busy and common spot. 
Their sales promotion is very similar to consumer goods. 
Sales Promotion of Ethical Products; 
Ethical products are said to be those for which a doctor's 
prescription is required without the recommendation of the 
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doctor, they cannot be purchased. These include antihypersen-
sitive, antidiabetic etc. 
The sales promotion of these products is done by various 
methods: 
1. Direct Mailing Literature to the Doctors; 
•l-'his is generally done when a new product is launched or 
some important improvement or development or change in price 
occurs on the product available. 
2. Advertising in Professional Journals; 
This advertising is done with the medical journals 
published from different places and souvenir published 
different medical associations, 
3. Visits of Medical Detailmen.or Representatives to the 
Doctor 
In every month or quarter a year the company's medical 
representative visits the doctors with literatures and some 
samples of the drug. There,the Medical Representative reminds 
to the doctors about the products of his company. 
4. Arranging Medical Film Show and Exhibition; 
Generally to launch a research product developed by the 
company or to overcome the competition when company is loosing 
share of its products in the market. 
5. Publishing of information of Medical Journals by the 
Pharmaceutical Companies; 
Presently many of the pharmaceutical companies have 
started publishing their own monthly magazines which gives the 
information and the latest report. It also gives the informa-
tion about the company's existing. 
6. Presenting Novelties: 
Like desk calender, prescription pads and compliments 
which serve as a reminder to the customer/doctor. 
This is the most important tool of pharmaceutical 
industry on which presently it is based. 
Job of, Medical Representative 
A Medical Representative in real sense is supposed to be 
a source of information and is the one,who informs doctors/ 
customers fully about his products and discusses new trial and 
uses of his company's products. He undergoes intensive 
training by specialized product training manager, which enable? 
him to present his product more confidently to the doctor/ 
customer. He is supposed to answer the quarries raised by the 
doctors. 
He is a trained professional man, who tackles chemists 
and is responsible for all the activities and sales in his 
territory. He has a particular area of coverage in his 
territory. He visits the doctors of the area and presents the 
known facts about his products, whether chemical,pharmaco-
physiological or clinical. 
Since he represents his company at the doctor's clinic, 
he is an immediate and direct source of information to the 
dqctor. If sometime the quarry is of such complexity which he 
IS 24 :: 
is unable to answer the doctor, it -is the duty of the Medical 
Representative to refer to his company's medical adviser for 
proper answer. 
Promotion Tools Provided to a Medical Representative; 
A Medical Representative is provided with a lot of 
information and many other tools to enable him to answer the 
quarries, as well as to present his product effectively. These 
tools are listed below: 
Literature/Visual Aid; 
These literatures of the company provide full information' 
about the product including pharmacological arid clinical. The 
literature also explains the dosage details, indications,contra-
indications, precautions etc. 
Samples; 
Samples of a product contains the original product but in 
small quantities or packing. These samples are provided to a 
medical representative for the doctors so. that they can try 
them on the' patients. But due to the increasing competitions and 
entry of new firms, sometimes samples are misused or mishandled. 
Novelties Items; 
This has become very common in this industry. Every 
second company now-a-days has adopted the policy of providing 
some complimentaries/gifts to the doctors. These gifts are 
generally pen, calenders, thermometer, diary, prescribing pad, 
pen stand etp. 
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Upto Date Information/Data : 
These days companies provide the medical representative 
with the latest published reports in India and abroad regar-
ding his products and competitive products. 
Detailing "; 
The representatives presentation of his products is 
normally referred to as 'Detailing' there has been a noticeable 
shift in the pattern of detailing in recent years. Previously, 
detailing mostly tried to emphasise the technical superiority 
of the product. Today, very few products can claim exclusive 
advantage over the competitive products available. Therefore, 
the emphasis is now shifting to detail products related to the 
benefits a patient would get with the use of a brand. 
SALES PROMOTION TOOLS 
Now the question to be studied in the techniques adopted 
by the industry tor sales promotion of the drugs produced. 
Sales promotion is vital in its importance and is internatio-
nal in character in each and every industry and, therefore, the 
pharmaceutical industry alone cannot be accepted as an exception. 
r r 
The competition has been causing a great inconvenience for the 
manufacturers to promote their sales. To face the trial of 
ability each pharmaceutical company is engaged in using sales 
promotion techniques of v^ arious types to sell more and more to 
get ahead of the other. 
The various sales promotion techniques adopted by the 
industry are ; 
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,A. Consumer/Prescriber Promotion; 
1. Persuassive detailing through Medical Representatives. 
2. Product sampling. 
3. Direct mail. 
4. Literature/handouts. 
5. Advertising in medical journals 
6. Scientific films 
7. Miscellaneous: 
(a) Clinical trials at hospital level 
(b) Participation in medical exhibition 
(c) Follow-up letters/pictures, post cards 
(d) Free gi'fts"" 
(e) Audo-visuals 
B. Sales Force Promotion : 
1. Field Staff commission 
2. Sales force contest 
3. Sales meeting 
4. Scientific seminars 
C,^ Trade Promotion 
1. Bonus scheme 
2. Discounts 
3. Dealers listed promotion (quality rebate schemes, 
price reduction). 
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Product Characteristics : 
Pharmaceutical products are meant for consumption of 
sick and weak hviman being and therefore, they heed to have a 
very high degree of reliability and safety. Popr quality, 
products can.play havoc with the life of patients and can 
subject the manufacturer to prosecution. It is therefore/ 
essential to assess the facilities for quality control before 
the selection of a particular product. It is particularly 
important for injectible preparation. 
It is not enough that the product should have active 
ingredients in sufficient quantities. But the product must be 
acceptable to patients. In the case of liquid preparation,taste 
and flavour plays a very important role. 
Pricing Pharmaceutical Products; 
Final retail prices of pharmaceutical products are 
governed^by drugs (price control) Order 1970. Under this order, 
a manufacturer puts up an application to government for prices 
approval,. He provides details of his costs which are scrutini-
zed by the Drug Committee of Ministry of Petroleum and Chemicals, 
After satisfying themselves with the details a manufacturer is 
given a mark-up of 4 5%, 50% or 100% over his costs tocover his 
marketing costs and profits and a maximum retail price is fixed. 
Different mark ups are given for different categories of 
products. 
In case the raw-material costs goes up, a manufacturer 
cannot increase the price of his product without obtaining prior 
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approval from the government. 
Drug prices control order had greatly reduced th6 profits 
of the drug companies. This order coupled with high cost of 
production had substantially increased the break-even volume 
of new introduction. Today^ introducing a new pharmaceutical 
product calls for a high degree of marketing effort and 
creativity. 
Distribution of Pharmaceutical Products; 
Though pharmaceutical products are ultimately consximed 
by the patients, the real consumer from marketing point of 
view is the doctor. He is the decision maker. The patient 
gets his medicine from the hospitals,doctors or from retailer 
chemists on a prescription. He has no direct influence over 
the medicines he buys. Yet he exercises his influence by 
giving his reaction to the doctor to various drugs. A drug 
which is not favoured by mo.st of the patients is not likely 
to be prescribed much by the doctor. 
Pharmaceutical products are sold by manufacturers 
directly to hospitals, registered doctors or to licenced dealers. 
^ 
The following channels alone or in combination are adopted 
to suit a particular marketing situation. 
Manufacturer 
Sole selling Wholesaler 
agents 
Hospitals Doctors 
Doctors - Retailer - Doctors 
Patients 
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DEr^ AND SUPPLY MODEL 
People 
I 
I 
I 
Health Needs 
Sickness Preventive 
Doctors 
^ 
Hospital 
T 
Chemist 
I / t 
Distributor 
4* 
i Drug Manufacturer ' 
Advertising OTC Products 
People 
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Selling Directly to Hospitals 
Sales to hospitals constitute an important sector of 
business for most pharroaceutical houses. Hospitals purchases 
are made mostly oh the basis of the sealed tenders. Therefore, 
there is a tendency on the part of most manufacturers to quote 
directly for hospitals tenders. In this way margins that are 
paid to the company can offer competitive prices. Sometimes, 
a manufacturer would prefer to route his hospital business 
also through his sole selling agents. This is done in order 
to save the botheration of collection of payments which is 
always a troublesome job with government institutions. 
Selling Directly to Doctors; 
Selling directly to doctors offer many advantages: 
1. It introduces new product to the doctors. 
2. >It ensures continued brand loyalty for existing products, 
3. It constitutes a certain sales as product purchased by a 
doctor are bound to be used by him. 
Because of the abpve advantages, a company may offer 
concessional price for the doctors. Part of the difference in 
price is compensated by the saving on margins to the inter-
mediaries. 
Promotion Budgets in Pharmaceuticals In India 
A survey report published by the Organization of Pharmaceu-
ticals Producers of India (O.P.P.I.) shows that on an average 
12.4% of the total turnover of a pharmaceutical company is 
spent on the sales promotion. The break-up as report published 
by the O.P.P.I. is as under: 
Percentage of total 
turnover 
1. Medical Representative 5.93 
2. Direct mailing shotjs 1.36 , 
3. Advertisement in Journals 0.82 
4. Free sampling 2.46 
5. Promotional activities like 1.82 
exhibitions and films 
12.40 
SourceI O.P.P.I. Report 
It is,however, understood by many people, even in the 
governmental circles that the pharmaceutical companies are 
spending millions of rupees on sales promotion activities, 
, by way of keeping medical representatives, distribution of free 
samples, mailing of expensive literature etc. They feel that 
these activities of the pharmaceutical companies do nothing 
but brain washing of the doctor to persuade them to use their 
products by brand name and making the consumer to pay heavier 
prices. 
BRAND ItJG 
Brand s 
A. brand name is a name, term, sign, symbol or design or 
a combination of them which is intended to identify the goods 
or services of one seller or group of sellers and to differen-
tiate them from those of the competitors.. 
As a corollary to the above definition a brand name may 
be defined as that part of a brand whi&h may be vocalised or 
utterable, A brand mark is that part of a brand which can be 
recognised but is not utterable, such as a symbol, design or 
distinctive colouring or lettering. 
Need for Branding : 
Although branding involves a cost to the manufacturer, 
but still each manufacturer goes in for branding mainly because 
of the following reasons i 
1. A brand mark is used for identification purposes. 
2. A brand name may be used as a legal trade mark, to 
protect the unique features of this product from 
inunitatlon. 
3. A brand name may be used to connote a certain quality, so 
as to promote repeated buying the brand recognition. 
4. Branding may be used as a basis for price differentiation. 
Criteria of a good brand name : 
A brand name should form an integral part of product 
development and designing. It should not be a casual after 
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though' of product manufacturer. The desirable qualities of a 
brand name are : 
1, It should suggest something about the characteristics 
of the product e.g. 
(a) The product Epileptin suggest that it can be used 
in cases of Epilepsy. 
(b) Similarly, Threocyclin suggest that it is a 
tetracyclin which can be administered three times 
a day (a unique feature of the product). 
(c) Sukcee suggests that it is a something which is 
meant to be sucked and it also pertains to taste. 
It is defined as the medicine with a taste. 
As an appendage to the above point, we can say that a 
product name should not be suggestive of a~ wrong characteristics 
e.g. the product Vitabiotic manufactured by IDPL was named so, 
keeping la a view that it is a vital antibiotic. But actually 
this name !• more suggestive of a compound which is a combina-
-tlon of a vitamin and an antibiotic. Such wrong suggestions 
afhould be avoided in product branding. 
Similarly, IDPL has named dexamethazone as Idizone. The 
product sounds as if it is a compound of phenylwodazone which 
Is not really so. 
Such misleading names should be avoided because they 
connote something different and may lead to faulty prescription 
of times. 
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2. h brand name should be easy to pronounce^ spell and 
remanber. It should be short and simple, so that it 
is not only registered in the mind of the prospect but 
is also easy to recall both verbally and in writing i.e. 
to say that a product name should be distinctive,e.g. 
Calmod was named by IDPL in accordance with the existing 
competitive product Calmpose. As a result Calmod could 
not establish its individuality in the market. In fact, 
the introduction of this product by IDPL gave a boost 
to the sales of Calmpose because of the similarity of 
names. The compaign for Calmod could not establish the 
product as intended. 
3, In pharmaceuticals, the name should be phonetically 
anglicised. 
Allopathic pharmaceutical preparations carrying 
indigenous names failed to capture the market. In-appro-
priate branding was a major factor in the failure of these 
products. 
(a) Calmod - Calmod is a musical ragn, which it believed 
infers peace and tranquility on the singer and the 
audience. 
(b) Sardilan - A preparation meant to combat colds, 
failed to establish itself because of its indigenous 
christening. 
(c) Avedan - A medicine meant to relieve pains '(i.e. 
Avedan) was also not accepted by the market. 
All these prx)ducts are being manufactured by IDPL. 
On the contrary Ayurvedic preparations manufactured by the 
Himalayan Drug Co.,principally from herbs and carrying anglicised 
names have captured a large market and are in fact very popular 
with the medical profession. Examples of these drugs are: 
(i) Liv.52 
(ii) Cistone 
(iii) Tentex Forte 
(iv) Speman Forte tablets for increasing the rate of 
spermatogenesis. 
4. In pharmaceuticals, the brand name of the drug should not 
connote the diseasje for which it is meant, particularly 
diseases like tuberculosis, leprosy and venereal diseases 
which cdrry a social stigma and cancer which carries a 
fatal appropriation. Moreover, if products are named 
highlighting the disease, it is also bad for the patients 
because they are perpetually reminded that they are victims 
of a particular disease i.e. they are apart from the normal 
people. This may have psychological implications. Doctors, 
also do not like to recommend such names: e.g. 
(a) Tibafen - manufactured by Suhrid Geigy .and recommended 
for tuberculosis failed to come up in the market 
because of the implication enlisted above. 
(b) Similarly Epileptin. manufactured by IDPL and recommen-
ded for epilepsy cannot be considered a sound brand 
name. 
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5. A brand name should not have any other meaning in another 
language e.g. Apidin. 
Basis for Selecting a Good Brand Name : 
A brand ijame may be selected based on any three of the 
following ways: 
I. A brand name may be selected, so as to highlight the 
salient features of the product i.e. its mode of action, 
dosage, advantages over existing and also over competitors 
products etc.,e.g. 
(i) Peaces - It is a cough syrup which causes deconges-
tion and clears the throat.The name highlights this 
very fact. 
(ii) Ingestion - This product helps in cases of indiges-
tion. 
(iii) Sulphabid - This name is suggestive of a drug which 
is a sulpha and can be administered twice a day. 
In this way, the characteristics of the product may be 
put to use, in selecting a good brand name. A rightly 
selected brand name will thus become self-explanatory and 
will also prove to be plus point in promotion with doctors. 
II. The name can highlights the contents of the products i.e. 
it can take into consideration the various components of 
the drug,e.g. 
Cebexin - B.ccMnplex + Vitamin C. 
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Apidin 
Hexavlt 
Cemizol 
Throroycin -
A.P.C. + Codine 
A compound of six vitamins 
Vitamin C + Metamizole 
Erythromycin 
Idifulvin -
Idicin 
All these products are being manufactured by IDPL 
and the rationale for these names lies in their components. 
III. The name of the company may also be highlighted with that 
of the drug. This can form another basis for branding a 
product, e.g. 
IDPL + Griseofulvin 
Indomethocin of IDPL 
Iditol - IDPL + Ethambutol 
Glaxene - Senna of Glaxo 
Crotorax HC- Hydrocortisone + Crotamitone of Suhrid-Geigy 
In this manner, we can name any product pharmaceuticals or 
otherwise. 
Inspite of the various advantages of branding, in price 
sensitive markets, it is better to sell pharmaceuticals under a 
generic name. Moreover, the government also charges an extra 
excise duty of 7-10 percent on branded pharmaceutical prepara-
tion e.g. in hospitals, IDPL is generally selling its product 
under a generic name, because it is a price sensitive market and 
a difference of 1-2 percent may also turn the tables. IDPL is 
marketing Tetracvclin. Analgin. Sulphaquanadine under its generic 
name. 
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hma&l mOm* for Branding ; 
1. The name should not be a proper noun e.g. (Usha Sewing 
Machine). 
2. It should not be a dictionary word since no one can 
exercise monopoly over a dictionary word (e.g. Sir, 
Shirts}. 
3. The name should not be descriptive of the nature of the 
product, 
4. The name should not give any idea regarding the contents 
of the product e.g. Analgin. 
5. The name should not be similar or even bear phonetical or 
Visual similarity to its generic nanae or any existing 
product e.g. Ptylin, For this dxrug we cannot win a name 
Tylin because it bears both a phonetical and visual 
similarity to its generic name. 
The manager, then has to decide on an appropriate name 
keeping in view the conflicting outline of legal regulations 
and the demand made by an enterprising business, 
Procesg of Registration of Names> 
Branding in itself is a separate entity for any product. 
It is a long process and a manufacturer has to coin a name with 
a lot of caution. Moreover, to attain the sole rights for the 
use of a name, the company has to get it registered with the 
register of trade marks. The registration of a brand name 
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involves the following steps: 
1. Coining of brand name; The first step in this process of 
registration involves the coining of a brand name, A brand name 
may be coined in accordance with any of the features enlisted 
in the preceeding page* To brand a product (particularly 
pharmaceutical)/the person must know: 
(a) Composition of the product 
(b) Its usage 
(c) Therapeutic classification i.e. antibiotic or 
synthetic drug. 
(d) Any advantage over the competitive product 
(e) Any other distinct features. 
(f) List of similar products already registeired* 
A good brand name may be coined keeping in view the above 
list i.e. by highlighting any one of the features given above. 
It is important that a large number of names should be coined 
and not just a single name since the chances of rejection during 
the subsequent phases are much more because of the increasing 
competition. 
2. Search and Feasibility Report : After the name has been 
coined, it is generally sent for search and feasibility. However, 
it is not obligatojry for a company or an individual to send the 
name for search and feasibility. All the same, it is helpful to 
get this report through the register, to- make sure that the name 
is not similar to already registered names and also to make sure 
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that the name is registerable i.e. whether it conforms to 
legal rul<»» or not, A nxomber of hames are sent for search and 
feasibility, so that a number of alternatives are available 
with the company and also if one name is rejected, other 
possibilities should be available. It takes about three months 
to finalise this report. 
Case : The name Okasulf was coined by IDPL for a scheduled 
drug which is in the form of drops. The search report revealed 
that the OXasa Company is manufacturing Okasules which are in 
the form of granules. 
However, this objection was over-ruled by the patent 
attorney on the ground that since the nature of the goods is 
different and they are to be sold only on the prescription of a 
medical practitioner, the chances of deception in trade are very 
few. Therefore, IDPL was advised to go ahead with the adoption 
of this name. 
3. Examination Repoirt : After the search and feasibility 
report has been received and the product is found fit for 
registration, an application is filed with the registrar for 
obtaining the final registration of the brand name. The 
registrar will critically examine the suggested name and will 
tell us whether it is similar or distinct. He will also tell 
us as regards the registerability of the name. Here also, it is 
better to send more n\imber of names since the chances of 
rejection are quite high. 
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Case : M/s IDPL coined a neme Eplleptin for a drug to be used 
for epilepsy. The search report for this nameu-was absolutely 
showing no conflict. But in the examination report sent by 
the Registrar an objection has been raised. The registrar 
stated that the name Epileptin bears a phonetical similarity 
to the name of the disease epilepsy and also the name describes 
the disease for which it is to be used. Hence registration was 
denied to the proposed name. 
But the company is still fighting the case and is trying 
to convince the registrar on the registerability of the name. 
The company has also proposed to use the name Epilepton. This 
has been done to protect the name from competitors. The case is 
however, still at an inconclusive stage. 
Advertisement : 
After the registrar has given his consent as to the 
registerability of the name, the opinion of the product is sought 
on the issue. An advertisement is issued in the brand name and 
trade mark journal. An objection can be raised by the interested 
parties within three months of publication of this advertisement. 
The objections are filed by the concerned parties and the counter 
statements are also sent to the registrar office by the party. 
A day of hearing is fixed for both the parties and the case is 
resolved. The company may have to withdraw the case under 
certain circumstances. If no objection is raised the name 
proposed is cleared and proceedings are undertaken for final 
registration. 
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Case ; IDPL proposed the name Bronchopet for a preparation 
recommended for respiratory troubles. The search report for 
this product should give the name Bronchordil. But since 
the name Bronchopet was not inconflict with the findings of 
the search, it was sent for examination.' The examination 
report was absolutely clear the registrar then advertised this 
name in the brand name and trade marks journal. Wheij this name 
was advertised/ M/s Jules & Co, the manufacturer of a prepara-
tion Brohchodrex, intervened and gave the full points against 
the registration of Bronchopet. They claimed phonetic and 
visual similarity and sai^ that since both the products were 
meant for the same purpose, there are chances of infringement 
of trade. 
IDPL replied to the above accusation saying: 
(1} That the name Bronchopet carried no implications of 
phonetical or visual similarity, 
(ii) It was also declared that a lot of brand names are 
carrying the prefix "Broncho" and as such Bronchopet 
will not infringe upon the sales of Bronchodrex as 
claimed by M/s Jules & Co. 
Final Registration; After the name has been cleared by the 
registrar and also no objection is raised to the use of the 
name by the public, the name is sent for final registration, A 
fixed amount of fee is deposited with the registrar and the 
registration is finally obtained. 
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Certificate of Registration; After a fixed amount of fee is 
deposited with the registrar for final registration, the-
registrar then issues a certificate to that effect. The sole 
rights for the use of the brand name are then reserved with 
the company and no other person is entitled to immitate the 
salient features of the product. 
However, it has been seen that registration is not a 
fool proof device for the protection of a brand name. There are 
many cases, where objections have been raised to the use of 
a particular name even afi/er the certificate of registration 
has been obtained. This complicates the process of branding 
even more. 
Case : (Protection of brand name) 
Hexavit Vs Bexavit : IDPL uses the name Hexavit for its 
multivitamin preparations. It had also obtained the registration 
for this name which is valid to date. This product is very 
popular and also selling well in the market. It was observed 
that Sarabhai had come up with a product Bexavit, a multivitamin 
preparations, IDPL, at this stage filed a case against Sarabhai 
stating phonetical and visual similarity of names. 
Initially, Sarabhai tried to fight the case denying any 
phonetical or visual similarity. IDPL suggested that they should 
change their name to Bexj-vit and restrict its manufacture only 
to tablets to avoid infringement of trade, A mutual understanding 
was arrived at and Sarabhai agreed to conform to the terms and 
conditions laid out by IDPL, This settled the case and the 
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DOSAGE FORMS AND THEIR STRENGTH 
Dosage forros are a very important target of sales 
promotion in pharmaceuticals. It is important that the drug to 
be administered should reach the site of action in the desired 
quality at the desired time and remain in the body for a 
desired duration. Not only that/ the form of the drug should 
be such that it is convenient to administer and also that 
minimum possible efforts are put into get the desired action. 
Also, it is important that a wide variety of dosage forms and 
strengths is at the disposal of the doctor, so that he can give 
prescriptions according to the needs of the individual patients. 
Thus it is necessary that the persons concerned with sales 
promotion are fully familiar regarding the general details and 
the forms in which a drug can be given. The drugs can be adminis-
tered by the following results! 
A . 
B . 
C . 
D. 
E. 
F . 
Orally 
Parenterally 
Anally 
Topically 
Nasally 
Vaginally 
A. Oral Administration : Oral administration of drugs is 
resorted to in cases where: 
(a) the drug is required in the gastrointestinal tract for its 
local action, e.g. in cases of antidiarrheal,antacid pre-
parations or digestive enzyme preparations. 
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(b) When the action of the drug is required in the extra-
intestinal site through its absorption from the gastro-
intestinal tract in the blood e.g. antibiotics, tetra-
cycline is administered by the oral route irrespective 
of the site of infection. 
A drug preparation to be administered should satisfy the 
following criteria : 
(i) The drug should not get destroyed by the secretions of 
the gastro-intestinal tract, 
(ii) Sy taking a certain quantity of the drug conveniently, 
the desired quantity of the drug should get absorbed so 
as to accomplish its purpose successfully. 
(iii) A drug administered orally, takes sometime to reach the 
site of action and therefore it is more convenient for 
diseases where life is not in danger and the loss in time 
can be tolerated. 
(iv) The drug should not irritate the gastro-intestinal tract 
very much. 
Orally, a drug can be given in various formsx 
(a) Powders 
(b) Granules 
(c) Tablets 
(d) Capsules 
(e) Liquids 
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(a) Powders : In solid form, one of the ways of giving a drug 
is in powder form. Usually the drugs are not marketed in 
powder form now, but where a bulk of the material is required 
to be taken, it is better to give it in powder form because a 
large number of tablets may not be convenient. However,medical 
practitioners do give drugs in powder form, mainly to distort 
the identity of the manufactured product. 
The disadvantages of giving drugs in the powdered form 
are : 
(i) It is difficult to measure the quantity to be taken, 
(ii) The powder sticks to the buccal cavity thereby 
giving its taste and even leaving it after swallowing. 
Therefore, it is not preferred in the modern age as 
compared to better dosage forms, 
(b) Granules : Drugs in the form of granules are certain 
quantities of powder bound together. It is usually given where 
drugs are required in bulk and it becomes impracticable to take 
tablets. Granules are manufactured to: 
(i) mask the taste of the powder through sugar coating 
or plastic coating. 
(ii)* To protect the drug from the action of gastrointestirial 
juices, so that they remain in tact in the stomach 
and are absorbed only in the intestine, 
(iii) Tableting adds to the cost of the drug and its 
use may be discontinued even though the drug is 
required for a longer period of time,e.g.IDPL is 
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manufacturing Na Pas granules, a drug meant for 
tuberculosis and also required for a longer 
duration. Its low price is a plus point in adding 
to its popularity. Moreover, these granules have 
been given or enteric qoating for protection 
against the action of gastro-intestinal juices and 
therefore allows absorption only in the intestines. 
(c) Tablets: When a certain quantity of powder or granules 
are bound together in solid form of a specific shape, a tablet 
is formed. Tablets may be manufactured of different shapes, 
colours and sizes. But these special features have to be 
imparted with a lot of caution, keeping in view the purposes, 
they meant to achieve. The colour of the tablets, many a times 
helps in adding to the saleability of the drug, for instancei 
(i) A tablet meant for increasing the quantum of blood 
manufactured in the body should invariably be red in 
colour to provide a sanguine effect, 
(ii) Vitamin tablets meant to give vitality to the body 
should not be black coloured. It should look lively 
also to impact the desired eminosity e.g. Hexavit 
tablets are in red colour. 
(iii) The tablets meant to be taken for a longer duration 
should be light coloured so that the patient does 
not get the impression of taking potent things. 
Usually, the tablets are round in shape, but sometimes a 
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shape other than round such as triangular or capsular form can 
be made to make the product distincts from similar products. 
Tablets in capsule form show that it is a more potent 
drug e.g. Cebexine tablets. The formation of tablets requires 
a certain amoxont of pressing^ so as to bind the powder or 
granules. Accordingly the tablets may be: 
(a) Hard pressed 
(b) Soft pressed 
A hard pressed tablet stands well and has a low dispersion 
power. 
A soft pressed tablet will disintegrate soon after inges-
tion and has a remarkable power of in a solution. The manufa-
cturer falls back on this feature to highlight the past action 
of the drug. 
Another important characteristic of tablets is its 
coating. Tablets may therefore be : 
(a) Coated 
(b) Uncoated 
A coating is given to the tablets for the following 
reasons: 
(i) To mask the bad taste of the drug. 
(ii) To ensure that the tablet does not get dissolved 
in the mouth, thereby giving a bad taste, 
(iii) To give protection to the drug against the action 
of the juices being secreted in the stomach, 
(iv) To prevent destruction of the drug during storage. 
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(v) Coating may also be given to make the drug easily 
swallowable. 
Types of Coating : 
(a) Sugar Coating : It is primarily given to mask the bad taste 
of the drug and also to make it easily swallowable. It 
does not provide any protection to the drug othervise. 
However, it is a very popular form of coating given to 
various drugs e.g. Hexavit, Ingestin and Melubrin of 
Ranbaxy. 
(b) Film Coating: 
(i) It is made up of some synthetic material. A drug 
under this synthetic mask will not only be protected during 
storage and from the action of juices once inside the stomach, 
but will also be rid of bad taste,experienced while swallowing. 
Film coating is considered to be an advanced over sugar coating 
and any product giving this sort of a coat will be considered 
to be more sophisticated and therefore more saleable. 
(ii) Film coating has no sugar taste and therefore it 
psychologically helps diabetic patients or people who otherwise 
want to avoid sugar, although the amount of sugar in a coating 
is almost negligible. 
(iii) Another advantage of film coating is that sugar may« 
sometimes react with the ingredients of the tablet in the pre-
sence of a little atmospheric moisture. 
(iv) A thick film covering may sometimes be given to the 
tablet, so that the ingredients of the drug do not get destroyed 
/ 
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in the stomach and it takes time to dissolve e.g.Thromycin-S. 
(c) Press Coating : This is another variation in coating. If 
there are two or three ingredients in a tablet and one of them 
is highly sensitive and the other material is relatively-
insensitive and tasteless also, a thin coating of sugar or film 
may prove to be ineffective in protecting the sensitive 
material. In such cases, the tablet is like any other ordinary 
tablet in appearance, but the sensitive material forms the core 
of the tablet and the insensitive forms the outer covering. 
Thus the sensitive ingredient is thoroughly protected by putting 
. a tablet within a tablet e.g. Cemizoletablets. 
Retard Tablets: These tablets are manufactured with the idea of 
saving the patient the inconvenience of taking tablets time and 
again. To remember the timings of various doses may be tiresome 
and the conseguences of missing a dose may be worse. These 
tablets are also designed that their fractions are dissolved 
and absorbed at different times after ingestion. In this fashion 
the dose of the whole day may be administered at one or two goes, 
Because of the retarded action spread over a'span of time, they 
have been labelled retard tablets e.g. Belanidal retard of 
'Sandoz', It is a tricoloured tablets and the same substance has 
been given in three different solubilities. The total contents 
of the tablets have been.divided physically into three parts and 
each gets dissolved at different times. 
Coating may proved to be undesirable in many cases since 
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it may inhibit the absorption of the drug. To away with such 
disadvantages, uncoated tablets are manufactured. The 
advantages of uncoated tablets are: 
(i) Coating of a tablet may at times delay or inhibit 
the absorption of the drug. Therefore, uncoated tablets are 
preferred over coated tablets e.g. Compeba tablets of IDPL is 
a bitter tablet in taste but are uncoated because any coating 
inhibits the absorption of this drug. 
(ii) In certain cases, only a part of the drug is required 
to be taken and so the tablets are required to be scored. Coated 
tablets cannot be scored e.g. Celenix tablets of IDPL, which 
are required for increasing the output of water in the form of 
urine (i.e. diuretic in nature). The quantity of the drug to be 
administered depends upon patient to patient. 
(d) Capsules : It is a drug enclosed in a small, soluble 
container of gelatine. The container may be composed of soft 
gelatine or hard gelatine. 
Needs for Capsules; 
1. Itmay not be possible to convert a drug in the form of a 
tablet of a desired concentration and the size may become 
quite unwieldly. 
2. The process of disintegration of a tablet takes a longer 
time, whereas the dissolution of gelatine is a quicker 
process and easier absorption since the drug within the 
gelatine is in a disintegrated form only. 
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3. The gelatine coating gives a lot of protection to the 
ingredients within. 
4. A capsule adds to the psychological potency of the drug 
and some people may prefer to take capsule over tablets. 
Types of Capsules; 
Capsules are mainly of four types: 
1. Hard Gelatine Capsules; They have an outer covering 
of a hard gelatinous substance and is made up of two 
portions. In these capsules, a powder is filled. The two 
parts of the caps^ ile may be interlocking by themselves 
or different coloured band may be put to ensure that 
the capsules are sealed fairly well, e.g. Tetracyclin 
capsule,Threocycline capsule. 
2. Soft Gelatine Capsules ; These have a sort outer covering, 
A paste form of the drug is put into it. These are 
hermetically sealed capsules. Mostly, haematonic prepa-
rations containing liver extracts are put in these capsules. 
They claim that their capsules are hermetically sealed 
and therefore, completely stable,e.g. Theraqram of TCF. 
3. Pearls : These are rounded capsules which are generally 
filled with an oily substance. They have a coating of 
soft gelatinous material e.g. Garlic pearls manufactured 
by Ranbaxy, Garlina pearls of PCI, And usually vitamin A 
and Vitamin D preparations are given in this form, e.g. 
Adoxilin of Glaxo. 
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4, Spansules : These are a distinct category of capsules in 
themselves. It has a hard outer covering of gelatine. 
Small pillets are put in it. These pillets are let out 
in the body upon dissolution of the outer covering. These 
pillets then disintegrate at various times after the 
capsule has been taken in. They are particularly for 
sustained action of the drug. Such preparations dispense 
off the need for taking doses twice and again taking one 
capsule a day is much more convenient as compared to 
taking three or four after a certain lapse of time during 
the day. 
(e) Liquids : Liquid preparation form a major portion of the 
oral administration. Liquid preparations are mainly given 
because of the following reasons: 
1, Liquids are prepared for convenience of administration 
especially for children and those fastidous patients who 
do not like to take the drug in a solid form. 
2. Certain patients who have problems in swallowing tablets 
and capsules are given liquid preparations. 
3, Certain drugs prove to be more fruitful in their action 
when given in the form of liquids than otherwise. 
4. In those preparations where the ingredients are in the 
form of a liquid. 
Liquid preparations in pharmaceuticals are mainly of the 
following types: 
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(i) Mixture : A combination of a fluid with another fluid 
or a fluid with a solid will lead to the formation of a mixture. 
Preparations of mixtures are generally given by the doctor. 
(ii) Suspension : A suspension is a finely divided solid 
svibstance,which does not dissolve in the liquid but remains 
suspended in it e.g. Almqel having a solution of Aluminium 
hydroxide and consisting the suspension of magnesium hydroxide. 
It is used to nullify the acidity of stomach. 
(iii) Elixir : An elixir is a clear, sweet and alcoholic 
liquid. 
(iv) Emulsion : An emulsion is a compound of two such 
liquids which are immiscible. 
(v) Syrup : It is a concentrated solution of a sugar 
with other ingredients. The syrup manufactured by IDPL are 
ingestion. Peaces and Cebecin. 
Syrup can be readymade or it may have to be made in those 
cases where a drug cannot be kept in a liquid form for a long 
period, the company may provide drug in the powdered form and 
sweeting agent, such preparations are called dry syrup,e.g. 
Thromycin-S of IDPL, Ciplin-DS of Cipla. 
(vi) Drops : They are clear solution of low viscosity 
which fall from a small opening e.g. Sukcee and Spasmiqol being 
manufactured by IDPL, Solubin-C and Mycidex of other companies. 
Physical Features of Oral Preparation; 
1, Taste : The teste of the drug also goes a long way in 
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adding to its saleability. It is very important that the taste 
of an oral preparation should not be an obstruction in the 
administration of the drug. 
In solid form such as tablets, the coated tablets always 
have an advantage over uncoated tablets because of -Che taste 
factor. Moreover certain tablets and liquid drugs gain popula-
rity just because of their taste e.g. 
(i) Sukcee manufactured by IDPL is a very popular 
vitamin-C preparation just because of its good taste. 
(ii) Vicks The very popular throat logenges sell well 
because of the wide variety of taste. 
(iii) The same is the case with Strepsils. 
In case of liquid preparations, taste is a very important 
factor. Particularly preparations like health tonic etc. are 
sought after mainly because of their good taste. However, 
different flavours have a different saleability according to 
the likes and dislikes of people. A good taste of any prepara-
tion Is generally banked upon as a sales promotion tactics,e.g. 
Phosphomin vitamin tonic of Sarabhai. 
2, Smell : Taste and smell of pharmaceutical preparation 
should go hand in hand. A good odour as good taste will achieve 
the same purpose doubly well. Usually, the solid forms do not 
have any smell. If certain unpleasant odours are found in them, 
care should be taken to mask such odours. Here, a word of 
caution needs to be added i.e. addition of flavours should not 
however inhibit the basic purpose of the drug. In case of certain 
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capsules, especially soft gelatine capsules containing liver 
extracts have a very bad smell. Any manufacturer gaining the 
ability to mask such an odour will definitely have a plus 
point there. It is also important that flavours should be 
added keeping in view the purpose of the drug e.g. Molizyme 
a preparation to combat indigestion is rightly flavoured with 
Heenq and Zeera etc. because these natural substances have a 
lot to do with digestion. 
3. Consistency : In cases of liquids, it is desirable that 
the liquids should be of low viscosity. Highly viscous or oily 
liquids tend to stick within the buccal cavity and leave an 
after taste in the m6uth. Such liquids may therefore not prove 
to be very popular among doctors and patients, e.g. Sharkoferrol 
of Alembic, Sharbat Paulad of Hamdard Laboratories. 
B, Parenterally : Injectable drugs also form a major category 
of dosage forms. Injectables are preferred over oral administra-
tion because of the following reasons; 
1. The drug in the form of tablets gets destroyed in the 
gastro-intestinal tract before it is absorbed in the blood. 
2. The drug may prove to be very irritant to the lining of 
gastro-intestinal tract. 
3. Proper quantity of the drug may not be given orally 
because a massive dose rfiay be required for the same purpose, 
As such, it is preferred to inject the dose. 
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4. To ensure that the drug shows irnmediate action, it is 
injected in the body. This is to shorteja the route via 
blood which is generally followed by oral administrations. 
5. In cases, where a person is so handicapped that oral 
administration of the drug is not possible, the drug is 
then injected into the body. 
A drug can be injected into the body by any one of the 
following methofisi 
(i) Intramuscular injection : In this method the drug is 
injected through a syringe and a needle in the muscles of the 
body. Usually the pelvic or pectoral muscles are used for 
int;ramuscular injection, e.g. 
(a) Fortified Procaine Benzyl Penicillin of IDPL 
for aqueous injection I.P. 20 Lac units, 
(b) Streptomycin sulphate I.P. 1.00 gm base of I.D.P.L. 
(c) Dicrysticin-S injection I.P. of Sarabhai. 
(ii) Intravenous inlection : In this case, the drug is 
injected directly in the veins, so as tomix with the blood 
immediately, e.g. 
(a) Trinergic injection of Alembic. 
(b) Vitneurin of Glaxo 
(c) Neurobion and Tri-radisole-H injection of other 
companies. 
(iii) Intra-arterial injection : In this case the drug is 
injected directly in the arteries. 
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(iv) Subcutaneous Injection : Here the drug is injected 
just beloW the epidermal layer of the skin, in such a manner 
that it does not penetrate the muscles, 
(v) Intratuccal : In this mode of injecting, the drug 
is administered in the spinal cord, 
(vi) Intraperitoneal i Here the drug is injected in the 
peritoneum of the body. 
(vii) In Bone Marrow : The drug is injected in the bone-
marrow, 
(viii) At site : A drug is injected at the site of action 
in certain cases of emergency e.g. if a drug is required to act 
at the heart, it is injected directly at the heart itself e.g. 
injection of Adrenalin, and Dexona injection of Cadi11a. 
An injection is generally given in the form of a liquid, 
but pharmaceutical preparations may or may not seen the form of 
a liquid because many a times, it is not possible to give a 
readymade solution, since it may be get determined with time 
during storage. In such cases, the drug is made available in 
the form of a powder and the doctor has to convert it into a 
liquid before injecting by adding either distilled water or 
any other solution provided by the manufacturer". The examples 
of powder injections are penicillin and streptomycin prepara-
tion manufactured by FDPC. 
A preparation available in the form of a ready to inject 
solution is preferred over dry injection. Injections are made 
available in the following forms: 
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1. An Ampule : An ampule usually of a glass contains the 
injectable solution. It contains one dose only. Generally all 
the intravenous injections are available in the form of an 
ampule, as it is most hygenic, contamination free, single dose. 
2. A Vial : The injectables can be available in the form of 
a vial also. Generally, all non-liquid preparations are given 
in the form of a vial only, so that the liquid can be easily 
syringed into it. Also, many intramuscular, liquid injections 
are given in this form and where more than one dose is to be 
provided for this mode of packaging is usually resorted to. 
This also allows for economy, 
3. Infusion bottle ; Injectibles like glucose and saline are 
generally provided in this form, since a continuous flow is 
required for hours together. They are used mostly for intravenous 
transfusions,e.g. Dextrose 5% solution. 
4. Hypospray : Certain injections can be administered without 
using a syringe and a needle. This is known as the Hypospray 
injection. In this method, there is a small rubber pump, 
connected with a glass container which holds the liquid injec-
tables. This glass container has a small jet and when pressure 
is applied with the upper pump, jet comes with a high velocity 
and that stream is so that pierces through the muscles. This 
method is applied for mass vaccination programmes, where a fixed 
amount is to be given to a large number of people. This method 
is time saving, economical and not at all fear provoking as 
other injectables. 
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Intranvuscular injection is given in the following cases: 
1. Where the drug is not observed orally or the drug gets 
destroyed in the gastrointestinal tract or the patient 
is unable to take the drug by mouth for one reason or 
the other. 
2. When quicker action is required,which is not possible by 
oral route. 
3. When'there is no other injectables route possible because 
of the nature of the drug. 
Intramuscular injections thereby permit the parentral 
administration of finally divided in soluble substances in 
suspension. The onset of action is slow and its duration 
prolonged. A depot of the drug is formed(in case of oily 
solutions) in the muscle and slow absorption occurs. 
In case of injections, emphasis on any orfe of the 
following points may offer the door to better sales promotion. 
1. The pain freeness of an injection is really a plus point 
in this regard. Particularly for intramuscular and sub-
cutaneous form of injections must manufacture and adequate 
amount of precaution should take them less painful. 
2. The syringeability of the injections is related to the 
viscosity of the liquid. The low viscosity of the inje-
ctables plays an important role in that, it can be injected 
into the body with greater ease, thereby nullifying the pain-
ful aspect of an injectables. 
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3. In case of non-liquid injections, the powder should be 
made up of fine particles, so that the suspension 
obtained after mixing in the liquid, can pass through 
the thinnest needle, since a pointed needle give much 
less pain. Also, if the powder can-be made of such a 
nature that is easily soluble in water without much 
shaping, it is going to provide a selling point there 
above the other competitors seems. 
On the basis of these three factors, a product offers a 
plus point over other similar products. 
C. Anal : This system of administration is very popular in 
many pairts of the world but not particularly so * in India, 
social institutions are the major factors for the use of this 
method. In our country oral drugs have more appeal as compared 
to anal route drugs. 
Drugs are given by the anal route in the following cases: 
1. When action is required only in the large intestine 
specially in the rectum and the colon e.g. drugs meant 
for piles. 
2. Certain drugs which are used for purgation have to be 
given anally because of the nature and site of their 
action e.g. Anemas concurously used for purgation. 
For children, it is very difficult to give a tablet 
of, a laxative and the preparation may not be available 
in the liquid form. It will be preferred to give the 
drug through the anal route. 
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3. Where the drug when taken orally either irritates the 
gastric mucosal of the stomach or the drug is destroyed 
by the gastric juices. The drug here is also given orally. 
For instance a drug known as Endomethocine is marketed 
all over the world. This drug is meant for pains in the 
joints and it has the property of irritating the mucosee 
and many patients cannot take the drug because it may 
cause unbearable pain. The drug is unavailable in India 
only for oral administration in the form of capsules. 
While in other countries, the drug is available for oral 
administration. A company which introduced the drug for 
oral administration failed miserably, 
4. Many drugs because their awful taste and smell cannot be 
given orally. Through the anal route, the drug is given 
in the form of a solid or liquid. In solid state, these 
drugs are known - Supposion i.e. cone shajsed solid mass 
or mass of solids and liquids. The drug in the form of 
suppositories is a selling plus point. But usually adminis-
tration of suppositories is not liked by the patients. 
In liquid form also, the drug can be given through the anal 
route. 
It is also important that any drug which is meant for anal 
route should be easily introduceable, otherwise the. drug may not 
be able to achieve its purpose. As a rule the rectal dose of 
most of the drugs is about the double of oral dose. The rectal 
absorption of drugs is more erratic than their absorption when 
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administered orally. Sometimes hyphotic drugs are also given 
rectally. 
D. Topically : The drugs meant for topical use can be in 
the form of a solution, an ointment, a cream or a powder. 
These drugs are meant for mainly,the ear, the eye, the skin and 
the gums etc. 
Any topical drug having the following characteristics will 
enjoy a better position in the market: 
1. These drugs should not cause any irritation at the site 
of action. 
2. Topical drugs meant for the use at throat and gums should 
have a good taste. 
3. The drugs should be non-greasy for skin applications. 
4. Also,topical drugs should be non-staining for skin 
applications and garments should be washable e.g. 
if a drug manufacturer can produce a clear solution of 
Gentian-Violet, he will capture the entire existing market, 
Examples of creams for topical application and powdersi 
(a) Betnovate-N,C&H of Glaxo. 
(b) Soframycin cream of Ethnor 
(c) Neosporin-S of Glaxo 
(d) Crotorax-H.C. and Plain of Suhrid Geigy,etc. 
E. Nasally : These drugs are usually volatile substances 
which when administered forms vapours which diffuse in the blood. 
Nasal preparations are of two types: 
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1, Local Use : These are in the form of nasal drops which 
are not volatile. Action is required in the upper 
respiratory tract. 
2. Internal Use : That is roubing the drug to the system 
through the nose e.g. Chloroform^ Ether. Nasal adminis-
tration should bear the following characteristics to 
enhance its sales i.e. promotion. 
(a) No staining to th6 nasal route. 
(b) No irritation to the nasal tract. 
(c) The solution should have a watery consistency 
because watery solution is preferred over an oily 
solution. 
F. Vaginal; The drug can also be given through the vaginal 
route. These drugs are given for the local infections of the 
vagina. They are also in the form of tablets of definite shape 
and size. These dosage forms are known as Suppositories or 
Pessaries. 
Appropriateness of the Dosage Form; 
The drug to be administered should be given in the form 
which is most convenient and also in keeping with the targeted 
market; 
1. Drugs meant for adults should preferably be in the form 
of tablets or capsules and not as liquids or drops so 
that there is ease in taking a dose. 
2. A tonic should generally be as a liquid. Generally, the 
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consxjoners cannot accept a tonic as a tablet. It generally 
connotes something in liquid form meant to give energy. 
3. Drugs meant for infants should be in the form of drops 
since it is difficult for infants to swallow in tablets 
and liquids. 
4. Similarly, it is preferable to give doses to children in 
the form of a liquid only. Children hate in taking the 
tablets because of their size and also their awful taste. 
Spectrum of Dosage Forrtis : 
In many cases,the drug may be used only in one form and 
it also has certain rare uses at times. Therefore, it becomes 
necessary to provide the drug in all possible dosage forms,e.g. 
(i) The product Erythromycin is generally sold in the 
form of tablets. The syrup is also manufactured for paediatric 
uses although it is not very popular. IDPL markets this drug 
under the name of Throroycin. Another company also markets this 
drug under the name of Erythromycin and it provides it both in 
the form of tablets and also as liquid. It may be noted that 
it is easier for the doctor to remember a single name and 
recommend the same for adults as well as for children. It would 
be tiresome for him to remember a separate name for adult doses 
and that for children doses. Thus this is the rationale for a 
number of dosage forms. 
Strength of Dosage Forms; 
Quantity of active drug in a single unit of a dosage form 
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i.e. one tablet, one capsule, 1 TSF/1 TbSP, 1-2 C.C. of intra-
muscular injection should be such that it makes the therapeutic 
dose enough to give the desired results in most of the cases, 
e.g.. usually, the oral dose of anpicillin is 500 mgs of it, 
4 times a day. In milder cases of infection, at times 250 mgs, 
4 times a day is prescribed. In short most times a prescription 
states 500 mgs.4 times a day. Obviously, a company giving 
250 mgs capsules alone, will not be able to sell the product 
better as compared to a company both 500 mgs and 250 mgs cap-
sules. IDPL manufacture, both 500 and 250 mgs capsules. 
Multiplicity of strength : 
When a drug specially in the form of tablet has different 
doses for different patients and types of diseases, it is 
appreciable to give the drug in the same dosage form but of 
various strengths. At times, it is also necessary to give the 
drug in various forms also depends upon the type of disease and 
type of patients, e.g. Metrolidazol is a drug used for various 
protozoal infections. The dosage varies 200 mgs 4 times a day 
to 400 mgs 3 times, a day depending upon the nature and severity 
of the disease. Here, a company providing dosage strength of 
200 and 400 mgs will score more over the other company providing 
either 200 or 400 mgs tablets. IDPL provides this drug under the 
name of Compeba in 200 mgs tablets. But its competitors have 
captured a larger share of the market since their sales promotion 
is more effective by the fact that they provide a wider range of 
dosage form,e.g. Trag 300, Zil 200 & 400 of Sarabhai, Flagyl and 
Metrozyl, etc. 
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PACK AND PACKAGING 
Packaging, under which a drug appears in the market, it 
is extremely important aspect of sales promotion, particularly 
so in pharmaceuticals. Here the customer cannot see the 
product or judge its quality by feeling it. As such, the 
customers verdict is based on the impeachable and meticulous 
packing. If the pack of a product is unsightly, he is bo\md to 
carry a bad opinion of the company and its product. As there 
is a famous saying of Urdu i.e. "the content of the letter can 
be judged by seeing th^ envelop or cover of the letter". So a 
good pack and packaging appeals more to the customers. 
There are two basic principles of packaging. 
1. Stability i The packaging of the drug should be such that 
the stability of the drug should be retained and there should be 
no interaction between the ingredients and the atmosphere or the 
ingredients and the packing material i.e. complete protection of 
the drug should be ensured. 
2. Elegance : The packaging of the product should be such 
so as to infer a distinctiveness on it. The packaging projects 
the product in a certain manner. Here the saying that "face is 
the index of the mind" holds true. Packing here represents the 
intrinsic quality of the product, since actually, it is very 
difficult for a doctor to differentiate the quality of one 
product over another of similar composition. The elegance 
offered by the packaging therefore also determines the salea-
bility of the product over similar products. 
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Packing of Oral Dosage Forms; 
1. Tablets : A tablet can be packaged in a n\imber of 
ways: (i) Bottles (ii) Strips. 
(i) Bottles; Packaging of tablets and capsules loose 
in bottles has both its merits and demerits. 
The merits of packing in bottles include mainly the 
economy provided in packaging. The cost of the packaging 
per unit comes down considerably by putting tablets and 
capsules in bottles. Also, this is preferred by the dispen-
sing doctors since they do not want that the patient should 
know what he is selling and at what price. Lo9se packaging 
may thus prove to be a selling point with doctors and 
hospitals e.g. Tetracycline. 
However, a nximber of disadvantages are attached with 
this mode of packing, which outweight the advantages. The 
disadvantages are; 
1. There is no protection to the individual tablets. 
2. If a bottle is broken, many tablets will be spoiled and 
as such, their maintenance proves to be troublesome. 
3. When we open the cap of a bottle and the tablets will 
be exposed to the moisture. 
4. An unscrupulous chemist may fill sub-standard products 
in the same bottles to sell loose and thus may cause 
harm to the company's name. 
Small quantities of tablets and capsules required for a 
days thereby may be put in vials. This is a very expensive 
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mode of packaging and therefore it becomes an inhibiting 
factor. However, in case of high priced products, it is always 
good to give a few in small bottles or vials, e.g. Vivocycline. 
IDPL^ is marketing this drug in vials of two capsules each of 
which forms a day's therapy. Since it is an expensive product, 
packaging it in vials adds to it distinctiveness. 
(ii) Strips : Tablets may be packaged in strips also. 
The strips may be of aluminium or of paper, e.g. Aspro is 
provided in paper strips. Enterocpiinol is also provided in 
paper strips. IDPL provides Analgin, Emizole etc. in paper 
strips. There are numerous advantages of packing tablets in 
the form of strips: 
1. Each tablet is provided in small power, giving total 
protection to each. 
2. There are no chances of breakage or damage which may be 
caused otherwise. 
3. It will inhibit the chemistis unscrupulous practices and 
will help in promoting the right drug. 
4. There is an ease of identification and it makes 'sure 
that the chemist does not use the wrong drug. 
5. Strip packaging prevents the unnecessary exposure of 
tablets to the moisture, which may take place otherwise. 
Aluminium foils are much more costlier as compared to 
paper foils. Even then, alumini\im foils are preferred for use, 
since paper foils at times may not prove to be moisture proof. 
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Pack Size ; 
The size ,of a particular pack is also a potent tool in 
sales promotion. Pack size refers to the quantity of the dnig 
in a particular pack. While packing a dmig, it is important 
to see that an adequate amount of it is allocated for each 
unit and also that the packaging may not contribute to a high 
price unnecessarily'; 
1. With regard to price, we consider two major factors. By 
giving a small pack, the medicine should not become 
costly per unit and by going a large pack, the price per 
pack should not go very high. It is therefore important 
to- strike a fine balance between the two, e.g. IDPL is 
giving Idiqlobin capsules in packs of 30 caps and 100 
caps both. In a pack of 30 caps, the retailer's price 
is Rs. 11,64 and price per capsule is 37 paise. In a pack 
of 100 caps, the retailer's price per pack is Rs.28.33, 
so the price per capsule is 28.33 paise. A patient may 
require a pack of 100 but may not have the ability to 
buy it. He may be instrumental in persuading the chemist 
to indulge in loose telling. This may automically will 
raise the price per cap. To avoid inconvenience to the 
patient but to provide economy, it would have been better 
to give only a pack of 30 caps. This will also limit the 
fradulence committed by the chemists, 
2. When a manufacturer decides to make a smaller pack, the 
dose should be given primary importance. Suppose the 
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daily dose of a drug is 4 tablets, it will be n^ ore 
appropriate to give the drug in a vial or in strips 
of 4. This will prove its worth with the patients 
also/ since they will not forget to take the dose/ and 
it will be economical also, e.g. _ 
- (i) The dose for Metacalfin and Melaxine (used for 
malaria) is two tablets. The entire treatment requires two 
tablets and of metacalfin or of 6 tablets of melaxine. Here, 
it is not advantageous to give strips of ten, since the chemist 
will have to cut out the strips before selling. At times 
certain patients fail to understand that the entire treatment 
can be finished in two tablets. They may indulge in over doses 
also. The doctors like to recommend such names and it helps 
in sales promotion also. 
(ii) Threocycline : The dose for this drug i.e.tetra-
cycline is one capsule 3 times a day (1 TDS). This drug is 
available in vials of 6 or strips of 6. The patient is required 
to take this- treatment for 4 days. Such an arrangement helps 
him to take the medicine in 2 lots depending upon his conve-
nience. 
3. The time required for a particular treatment is also an 
important determinant of thepack size. The pack size should 
contain the quantity which would be required during the time 
for that treatment to avoid the inconvenience of repeat buying 
and also to provide the economy of bulk buying to the patients. 
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Packaging of Liquid : 
Liquid preparations are packed generally in bottles. The 
injectibles will,however/ appear as ampules or an vials. In 
case of these preparations, the size of the bottles, its 
shape and colour play a very important role. 
The size of the bottle should be a convenient one. Its 
contents should provide for the entire treatment or a part 
thereof. The pack size should be such that it does not have 
a prohibitive price per unit and also it should not make an 
attempt to introduce economy through unwieldly pack sizes. 
Appropriate sizes are very important in drugs which have a 
specified dosage and time of treatment. However in case of non-
specific, high priced preparation such as tonics and other 
vitamins, which are generally consumed by the lite class, 
companies should try to achieve larger sales volumes by intro-
ducing bigger pack sizes, siftce the duration ofintake is not 
prescribed and the therapy contains till the preparation lasts. 
Here, it is advantageous to introduce larger sizes, because 
a customer has the inclination of buying a smaller size 
available and when the bottle is consumed, he has the satis-
faction of having adhered to the doctors pr-escription. If only 
a larger pack is introduced, he will buy that and continue the 
therapy for a longer period. 
A classic example of this is the tonics Sentivini and 
B,G. Phos introduced by Sandoz and Merck Sharp and Dohme 
respectively. B.G. Phos has been provided in sizes of 456 ml. 
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228 ml and 114 ml keeping in view the customers convenience. 
On the other hand Sentivini is available only in the form of 
360 ml pack. It has been found that B.G.Phos is more 
popular with the doctors i.e. it is prescribed more often 
than Sentivini. The sales prescription usually materialises 
either in the 114 ml and 228 ml pack. While each prescription 
of Sentivini results in the sale of 360 ml pack. Here, although 
the quantity and number of bottles sales of B.G.Phos are more, 
but the rupee sales of Sentivini are higher. At present,E.G. 
Phos can really secure a major chunk of the market by merely 
altering their pack sizes. 
Shape : 
Shape of the package (though not a very important aspect 
in pharmaceuticals) does exercise influence in case of non-
specific drugs i.e. tonics etc. However, it is necessary that 
the shape should impart elegance to the pack on the whole,since 
elegance here has to cohvey a lot of its prospective customers. 
It is important that the shape should impart stability to the 
bottle, i.e. it should not be shaky such that is tilts easily 
leading to the damage. Also, the cap of the bottle should be such 
that it should break open without undue efforts i.e. it should 
not require the use of a knife etc, 
A bottle with or without a carton has difference in its 
selling. A carton has two main advantages: 
1. A carton is instriimental in cutting off the light, 
2. A carton provides extra protection apart from providing 
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elegance. 
The impact of the importance of shape in tonic prepa-
rations can be seen in the example of Sentivini and Vitahext 
of Sandoz and Hoechst pharmaceuticals Ltd, Both of these 
tonics introduced by companies of repute simultaneously. The 
bottles of the two have a unique shape. However, the packing 
of Sentivini is more appealing leading to instant acceptance 
in the market. While on the other hand, Vitahext failed by 
virtue of its unappealing shape. 
This really provides an insight into the human psyche. 
The tendency of accepting all glittering things without really 
knowing whether it is gold or not; this is where, sales 
promotion has to hit, the htaman psychology and to adapt it in 
such a way, so as to farther its products. 
Colour : The' colour of the bottle in which the product is 
packed, is also very important factor in farthering the sales 
of liquid preparations. Colour plays an important role in the 
following cases. 
1. For those drugs, where the colour is not very appealing 
and cannot be made so, a clear glass bottle will only 
prove to be a disadvantage, since the patient will get 
an aversion to it, by the very look of it. Generally, 
amber coloured glass is used to mask the bad colour of 
the drug, e.g. Santevini of Sandoz and Diqeplex of TCF. 
2. In case of drugs where the colour is very attractive and 
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its stability remains unaffected by light, it is good 
to have a clear glass bottle, to take advantage of the 
appealing colour. Masking the colour might prove to be 
a disadvantage,e.g. Phosphomin of Sarabhai and Halib-
oranqe of Glaxo. 
3. If a drug is affected by light (which may lead to its 
break down) then irrespective of its colour, the drug 
will have to be given in a dark bottle, • 
These basic guidelines are of very much advantage for an 
effective sales promotion. 
Packing of Injectibles; 
Injectible solution are usually provided in the form of 
ampules or vials. In injectibles, purity is a point which has-
to be exaggerated. The doctor has to be convinced that not 
only the drug has been manufactured scientifically, but that 
the packing also carries scientific elements. He should be 
ensured that the drug is absolutely'stable and has high class 
packing. In case of injectibles, it is important that -
1. There should be no interaction between the drug and the 
glass which holds it. 
2. The glass should be such that, it should be even from 
inside, since there is a tendency of the drugs to 
interact much more at those sites which are uneven.They 
form active sockets which may destroy the drug. 
3. For highly active s\ibstances, it is important to give aj 
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coating of some inert substances like Silicin on the 
inner surface of the glass, to prevent such reactions. 
4. In case of solutions affected by light use of coloured 
glass is the best remedy. To prevent action of light, 
usually amber coloured glass ampules or vials are used 
or a paper jacket on the ampules or vials are used to 
serve the same purpose. 
All the above points, if highlighted cani prove tobe 
very effective for sales promotion. 
Pack Size : 
When an injection is given in a vial for making more 
than one dose for the same patient or for administration in 
different patients, the quantity of the liquid should be such 
that it can be consumed in a day or two. It may prove tobe 
unhygienic for the drug to be partially consumed for more than 
a certain time limit, e.g. IDPL provides multidose vials of 
Otcin. They should be consumed within two days of its first use. 
Secondary Packing i 
Usually, an injection should be given in an individual 
carton to provide extra protection both in cases of ampules and 
vials. For the purpose of economy, a set of ampules may be given 
in a single carton. However, this may prove to be disadvantageous, 
since any damaging effect may result in the breakage of all 
ampules or spliting^over of one ampule may result in the 
spoilage of all others. Thus, a compromise for economy should 
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be made with greater caution,e.g. Vitneurin of Glaxo, Trinerqic 
of unichem« Neurobion and Triradisol-H. 
In general, for packing of the drug, a good quality of 
material whether paper, alumini\im glass or board should be 
used. The workmanship should reflect the precision of work. 
The printing of labels etc. should be veiry neat and attractive 
with proper colour schemes etc. 
,< 
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PRICING 
Pricing is a very important aspect of sales promotion, 
particularly so in price sensitive markets. Prices have a 
lot of impact in the consumer markets and they are capable 
of guiding decisions of the prospective customers. The 
impact of pricing is not substantial in the pharmaceuticals 
market. The prices for this industry are fixed"by statutory 
provision under the Drug Price Control Order, This law 
ensures that undue fluctuations in prices are avoided and all 
customers get their commodity at a fair price. Since the 
prices are fixed, the manufacturer cannot bank upon it much 
to push their product, this thereby culminating in a battle 
for quality products. This law therefore relieves the custo-
mers of economic stress and ensures that the competitive 
manufacturers get nominal profits. 
Under the Drug Price Control Order : 
1, The prices of the raw-material used for the manufacture 
of drugs is fixed. Raw material may be here indigenous 
or imported. 
2, The conversion cost of the drug is also fixed i.e. the 
conversion of raw materials to intermediates land finally 
tablets,capsules, liquids etc, carries a stipulated cost. 
3, The cost of the packing of the product before sending it 
to the market is also given to each manufacturer. 
If a company can offer a standard product at a lower 
:: 79 :: 
price as compared to anotherstandard competitive product by 
either bearing a reduction in its profits or through improved 
efficiency of production, the lowered price product will be 
preferred, giving a selling point to the manufacturer. 
Similarly, if a standard company raises the price of 
its product and it can convince the customer that the high 
price is justified, either because of a superior manufactu-
ring technique, a new component added to the drug or because 
of improved packing, he will definitely accept the product. A 
higher price here does not offer any hinderance to the sale of 
drug. 
For certain life saving drugs, which are required in 
smaller quantities mainly for serious ailment, lowering the 
price does not help in filing the product. In fact a lower 
price may actually prove to be a disadvantage tothe manufacturer, 
because most of times quality is attached with price. A lower 
price may depict a poor quality and thus the strategy of a price 
reduction may back fire, leaving the manufacturer no where. Here 
a product having a higher price may gain advantage. 
The same would be true even for sophisticated products 
meant for the higher income strata group. This includes tonics 
and high concentration Vitamin preparations having semi-medical 
values. A high price in these cases plays to the advantage of 
the manufacturer. However, he has to hit the target by pointing 
out something unique about the product which justifies its high 
price. 
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Cases where low prices effects ; 
1. When the drugs are required to be sold to hospitals or 
dispensing doctors, price plays a major role. In case 
of hospitals, the goods ^re taken on the basis of 
lower tender offered by the manufacturers. In case of 
dispensing doctors, a lower price not compromising 
quality will definitely click, sipce the doctor can 
have the advantage of higher profits. However, in these 
cases also, a company gets some allowance for its high 
quality. 
2. When the drug is required to be taken for a very long 
period of time and the disease is prevalent in the slower 
income group, price will' play a very important role,e.g. 
Anti-tuberculosis drug should necessarily carry a low 
price because it has to be dispersed for months together 
and also the consuming class for this drug is the lower 
income group. So would be the case in the drug for leprosy, 
3. How price also plays an important role in sales promotion, 
when the drug is required to be sold directly by the 
retail chemists to the patients without the prescription 
of a doctor or on the prescription of ^ doctor, not speci-
fying any brand name, e.g. Tetracycline capsules may be 
recommended. A customer not really aware of the numerous 
brands will just go and ask for the tetracycline capsuies. 
The chemists will give him a cheap brand which is priced 
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lower and offers a higher profit margin. 
4. A low priced product may always speak of bad quality. 
Therefore, whenever a standard product is being given 
a low price, an explanation must be available for the 
difference in price as compared with other competitive 
products. If such an explanation is not given, the 
product may be labelled as cheap and this may affect 
the product, otherwise we should claim our product to 
be economical and give a reasonable explanation for it. 
Even for high priced products we should point out that 
the product provides us certain unique features which 
the existing brands do not provide and this makes our 
product economical, e.g. Cebexin syrup manufactured by. 
IDPL carries a high price. 
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BONUS OFFERS 
Another strategy of sales promotion is the bonus offers, 
A bonus offers is given in order to couple the efforts of the 
company with that of the external agencies responsible for 
selling. The stockists have to be motivated, so that they 
push a particular companies product better as codipared to 
its competitors. Better terms and conditions have to be 
offered to secure this deal and moreover this has to be done 
without really making the chemist or doctor feel that he is 
patronizing the company. The retailer is thereby induced to 
put in greater effort through the allurement of bonus offers. 
Companies periodically give bonus offers in the form of 
cash discount or in kind. The actual price of the product, 
however, remains unchanged for the f inalconstimer. The bonus 
offer may be made in any of the following ways: 
1. For the purchase of a certain fixed quantity of a 
particular drug, a certain quantity of that drug is 
given free of cost. 
2. For the purchase of a certain quantity of a drug, a 
fixed amount of another drug is given free of.cost. 
3. For the purchase of a certain quantity of a drug, a cash 
discount is allowed. 
In this way, we are not actually decreasing the price of 
the product but per unit cost of the retailer does come down 
and he stands to gain. This influences him to sell more by his 
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own efforts. Moreover, when these offers are in operation, a 
chemist tends to stock more than he usually does, so as to 
accrue the benefit of the deal over a longer period. This 
will help in putting the competitor's product in the shadows 
and the company will gain through the improved efforts. Bonus 
offers is resorted to under the following circumstances: 
1. To induce the chemist to stock a product, before its 
demand is created i.e. when the product is in the 
introductory stage and the establishment of the product 
is uncertain. At this stage a high margin on the product 
is offered as a bonus. 
2. To popularize the product in a shorter time, bonus is 
often given. 
3. When the inventory of the product is very high and the 
company wants to dispose off its stocks in a short 
period. 
4. When the company is in a financial crisis and wants to 
sell its product as early as possible so as to convert 
the material possession into cash. 
5. When the product is nearing expiry and its early disposal 
and use is of utmost importance, in order to avoid losses. 
6. When a competitive product has reduced the overall price 
by offering a bonus, in this situation a similar offer 
will have to be. resorted to in order to ensure the market 
share. 
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7. When a company is planning to discontinue a product, 
it offers bonus to ensure that all stocks of the 
product are depleted. 
8. When the company wants to present the same product in a 
different packing, it has tomake sure that the previous 
stocks are exhausted in order to give an entirely new 
projections of the product. 
Under these circumstances, -the company offers higher 
gains temporarily to its customers. But actually, it serves 
its own purpose i.e. of overcoming outward situation. The 
cost of such offers though prohibitive still leaves the 
company with nominal profits. 
Bonus is of particular importance in the pharmaceutical 
industry, more so, when a product is introduced in the medical 
profession. In this situation, the chemist do not want to stock 
new products for fear of non-acceptance by the customers which 
may result in blocked investment. The industry,however,wants, 
to ensure that no prescription goes unhorned at a retail 
counter so that people establish their confidence with the 
company. This is important because if a patient goes to the 
doctor repeatedly for prescription because of the non-availa-
bility of the product, the doctor may not recommend the drug 
again. Therefore to give the impetus to the sellers,allurement 
of additional profit is provided through introductory discounts 
or cash bonus offers. 
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Another advantage of giving a periodic bonus is that 
you can gain the loyalty of the chemists because they are 
sure of nominal profits. They i.e. druggist therefore place a 
lot of confidence in them. Such strategic moves on the part 
of the company therefore sxdastantiate its sales promotion 
efforts. 
Bonus Scheme for B~Complex Syrup : 
To boost the sales of B-complex syrup and to licjuidate 
short expiry stocks a bonus offer of one bottle of 110 ml free 
for the purchase of eveiry ten bottles of 110 ml. was proposed. 
And also one bottle of 450 ml free for the purchase of every 
10 bottles of 450 ml for a period of 3 months was proposed. 
A considerable rise in the total sales was achieved as a 
result of this bonus offer. In order to give maximxam rise to 
the sales promotion efforts and to achieve maxim\im sales in 
order to liquidate short expiry stocks, the bonus offer was 
extended for another month. This led IDPL to gain a lot in 
terms of cash sales which would have been lost and coupled 
with the burden of expired stocks. 
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INCENTIVE SCHEMES 
The Sales Promotion Department is also entrusted with 
the job of providing adequate compensation to the employed 
field personnel. Personal selling being an important tool 
on the promotional front, it is imperative that steps be 
taken to enhance the working of the sales force. Employee's 
compensation can be used for two basic purposes! 
i. To attract and retain qualified personnel in the 
organisation. 
2. To motivate these personnel to higher levels of perfor-
mance. The proper establishment of base pay for the job 
is directed towards the first purpose. Monetary and 
non-monetary compensation over and above the base pay 
may be used to achieve the second purpose. However, 
monetary compensation is the most commonly administered. 
In this chapter an insight has been provided into the 
highlights of the incentive scheme for field personnel. This 
scheme is changed from time to time to make it more comprehen-
sive. The incentive scheme for 1983-84 also proves to be one 
such comprehensive venture. The main feature of the scheme 
are listed below: 
1. This scheme is largely concerned with motivating the 
field personnel. It provides an opportunity to each 
individual to supplement his income during the year, the 
additional income being linked to the performance. 
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2. It provides for a quarterly system of evaluation and 
subsequent control. Since the medical representative 
has to fulfil the quarterly target and also the yearly 
target to be eligible for incentive; it keeps him on 
his toes throughout the year and thus ensures efficient 
working. The target selling is also done on a quarterly 
basis. Limits have been placed on the total amount of 
incentive a medical representative clan earn. 
3. The incentive scheme, being a rolling plant provides 
flexibility in promotions depending on the sales plan 
of the quarter, availability of producer's inventory, 
seasonal variations and competitor's activities. 
4. The concept of annual base target has been introduced 
in this scheme for individuals, as the qualifying level 
for incentive eligibility. This base target is proposed 
to be 10 percent more than the individuals representative 
performance in the previous year for the same territory. 
This ensures an annual growth rate of 10 percent for the 
organisation, 
5. The incentive also stipulates that the trade sales will 
be credited only when the money is realised within 45 days 
of raising the invoice. This time period is 60 days for 
institutional sales. This clause provides a proper check 
on efficient realisation of sales and also provides an 
insight into the credibility of the customer. 
6. The incentive scheme provides for an earning of Rs,500/- on 
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the achievement of 80 percent of the assigned target. 
This acts as a motivating factor for the slow worker 
also in that it pushes up his morale and gives him 
the satisfaction of having achieved something. It is 
very likely that he will work with gusto to achieve 
his next target. 
7. The incentive scheme is uniform for both trade and 
institutional sales. This then provides the represen-
tative with mixed territories, opportunities to do 
equal justices to both the categories of jobs. 
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PRODUCT PROFILE 
The purpose of all marketing is to satisfy the needs 
and desires of the customer. It is this ability of the 
seller to design a product which best satisfies these needs 
and desires, which ultimately determines market success or 
failure. In each purchase, he makes, he also seeks the fulfil-
ment of an obscure need. This is related more with psycholo-
gical utility of the product. Customer in his purchase, in 
buying a selection of benefits rather than a collection of 
product feature. Physical features of the product remains 
constant, the utilities enjoyed by him will depend upon how 
the manufacturer projects thfe product. This projection of the 
product in a particular fashion is known as the 'product profile' 
There are two aspects of product profile: 
1. Technical Profile; 
Technical profile gives the total and true story of the 
product. It highlights all the plus and the negative points 
about the product. It also tells as how our product fulfils 
the needs of the customer both spurious and latent in relation 
to the competitive product. A detailed study would help us to 
know what other needs of the people can be exploited, what 
other needs a product can be made to fulfil. A detailed study 
of the product is therefore necessary before the product is 
promoted. A marketer has to bank upon the product characterise 
tics for its promotion. 
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2, Market Profile : 
The second aspect of the product profile is the market 
profile. Market's today have been defined as 'People'. 
People form the hub of all the activities of a marketer. 
All the activities are oriented to the customer. To do this, 
he projects his product in a particular fashion which appeals 
to the customer and is in harmony with his needs and it caters 
the demand of the market. 
The marketeer uses this tool to confer the individuality 
on his product. He wants his product to be recognized in a 
particular manner which will be different from that of 
competitors and psychologically satisfying a different set of 
needs. 
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MARKET PROFILE 
In a competitive market, the manufacturer strives 
continuously to establish his share of the market. To do this, 
he gives an individuality to his product by projecting it in 
a manner which appeals to the target market. To infer a 
profile on the product, he will need to identify those product 
attributes to which his target segment is most sensitive and 
develops and promote them. The manufacturer has to see what 
the competitors are stressing and has to find areas of counter-
actions in developing the market profile of a product. To 
achieve this aim the manufacturers are increasingly using 
design themes, visual symbols and slogans to establish optimum 
customer perceptions of where they wish their product to stand 
in relation to the market as a whole. So a marketing manager 
has a host of strategic and tactical decisions to make in 
relation to his product. 
The market profile of a product should fulfil two basic 
requirements: 
1, The market profile should suggest something,which the 
prospect is looking for, or it should appear to fulfil 
the needs of the prospect or a dominant desire. This is 
called the •Hot-Button'. If the hot-button is not 
identified properly, sales promotion will not be able to 
achieve the required results. Market profile is not the 
presentation of a fictitious pictures or deception of 
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prospects. In fact it is the projection of positive 
facts which are helpful in selling the product. 
2. The market profile should be capable of impinging upon 
the minds of the people and it should be established 
there. It should have such an impact that they should 
know about the product and the prospect should be able 
to associate the profile with that particular product. 
People should have sufficient proof to believe that the 
profile is really an attach of the product. People should 
register that particular profile in their minds apd should 
be able to recall the name of the product when an effort 
is made in that direction. People should also be apply 
what they have registered and their buying motives 
should be in accordance. 
Depending upon whether the market profile satisfies the 
above check list or not it may accordingly be; 
(a) Appropriate 
(b) Inappropriate 
(a) Appropriate : A market profile may be appropriate but 
not established, people may not feel convinced about the idea 
propounded by the manufacturer. He will have to put in more 
efforts in his promotional campaign to ensure the prospects 
that such features are actually associated with his product. 
It should be appropriate in relation to the segment it caters 
to. A product unable to give any advantage will not sell since 
repeat buying will reveal to the customer that the product betrays 
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its popularized profile. It is for selling a good product 
that good sales promotion is required. 
(b) Inappropriate : A good product given a wrong projection 
will also fail to sell i.e. the market profile of the product 
is inappropriate. A bad product trying to prove itself 
through a wrongly coined profile will also be unable to sell, 
because the product will not authentify what the profile 
intends. Thus the profile will prove to be inappropriate. It 
is very common in pharmaceuticals, to coin a slogan highlighting 
the products. The slogan may be coined keeping in view the 
priority needs of the prospect. This slogan is usually entitled 
the Unique Selling Proposition (USP). The market profile may 
contain the more than one aspect of the product. For instance, 
the market profile may be a composition of : (i) Safety, 
(ii) Efficiency, and (iii) Economy. However, all the three 
may not be important for the intended market. Here we shall 
coin the USP, keeping in view the most important need of the 
prospect, so as to gain the maximvm* attention from the customer. 
To attract attention,the cause or affect of the drug is visua-
lised. That is what the prospect registers and he associates 
the drug iimnediately with the visual,e.g. Cemizol. This drug 
is a popular pain reliever and it also contains vitamin-C. The 
market profile of this product is; 
(a) Quick onset of action. 
(b) High magnitude of action 
(c) Contains vitamin-C 
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Here the first two points are very important for any 
customer. But the competitc?rs have banked upon these 
, features to promote the product and a projection of Cemizol 
ba^ed on these two points would have been another repetition 
without any distinctness. Therefore to-make the USP distinct 
IDPL also accounted for the third feature and the USP coined 
was "Fast and Potent Analgesic with a built in Advantage". 
This really clicked in favour of IDPL. Thus USP is the hub 
around which the sales promotion of any product is centred 
and sales promotion conducted without a USP is unscientific. 
PROFIIJE OF SUKCEE 
It was observed throxi^ h market research that vitamin-C 
was becoming exceedingly popular in the medical profession. 
Many reports from international markets stated the importance 
of vitamin-C, Doctors also started recommending this drug even 
for common colds. It was a-common belief that the vitamin-C 
requirements of the patient increase during diseased condition, 
therefore, it was recommended for ailing and normal patients 
both. But the bad taste of vitamin-C became an inhibition 
towards its frequent intake. Under this circumstances, it 
became necessary to mask the taste of vitamin-C, It was 
established that a good taste and flavour would play an impor-
tant role towards its selling. This fact was further substan-
tiated by the introduction of "Chewcee" by "Lederle". This was 
the first Introduction of a vitamin-C with a pleasant taste. 
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IDPL, worked on the development of a sweet and sour 
taste for vitamin-C. They became successful in producing 
such a taste for this very popularised drug. Since the 
main stake of the brand was taste and flavour, this was 
taken care off since the very beginning. The following 
points will elucidate how IDPL was successful in projecting 
the profile of this brand as "Medicine with a taste". 
1. At the first hand, the name of the drug itself attracts 
enough attention as being something related with good 
taste. The name "Chewcee" was thought to be a misnomer, 
since a tablet is expected to be sucked and not chewed 
to have the maximxam advantage of its taste and flavour. 
Therefore, the very name "Sukcee" connotes good taste 
and as such is very intimately related to its profile. 
2. The packing of the product is in strips and drops as well, 
One strip is of 10 tablets and pediatric drops are in a 
bottle of 15 ml with graduated droper. The strips are 
coloured green and lemon. This definitely goes towards 
expressing a sweet and sour taste since these two colours 
are connected with the citrus family. 
3. The colour of tablet i.e. lemon coloured with speck of 
orange is surely an allurement to the palate. The size 
of the tablet is such that it cannot be swallowed easily 
and it has to be sucked in the mouth before it can be 
taken in. 
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4. The first literature of the product projected a small 
girl taking vitamin-C drops as carrying an expression 
as though she was thoroughly enjoying taking this 
Sukcee. 
5. When the product was introduced, the doctors and 
chemists were made to taste the drug to ensure the good 
taste. Not only that, at each subsequent visit of sales 
representative, the doctor was made to taste the tablet 
with the contention that the taste was seen further 
improved. This really established taste as a factor in 
the mind of the doctor and he was then inclined to 
prescribe Sukcee whenever a vitamin-C was required. 
All these efforts were very helpful in projecting the 
medicine with a taste. In fact all these promotional efforts 
over confused the product at a particular stage. Because of 
its good taste, it was regarded as a sophisticated product and 
therefore the doctors limited his prescription to a certain class 
of people# At this stage then, price was emphasized along with 
taste. The doctors were convinced that the product is selling 
at a very reasonable price and that actually it i;^  a product 
for the masses. It v;as here that it was popularised as a 
product for the masses in order to protect the market share. 
Later to provide fill-up to this very idea, the product was 
also introduced in the forms of drops, so that it could be 
administered with ease to both adults and children. 
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Sukcee is a brand leader in Vitamin-C presently. It 
has established itself very firmly and is in fact taking 
away the market of Redaxon being manufactured by "Roche" 
and "Celin" being manufactured by Glaxo, 
Sukcee has been successful in attaining the status of 
a leader by virtue, of its appropriate projection i.e. good 
taste. IDPL has really given the proper profile to its 
product through identification of the "hot button". The 
efforts made in projecting this profile has been equally 
diligent. 
This case vividly reveals the importance of an appro-
priate profile and the efforts involved in projecting that 
profile. 
PROFILE OF THROMYCIN FAMILY 
IDPL manufacture three items as a brand name of Thromycin: 
1. Thromycin tablets containing Eirythromycin Es to late. 
2. Thromycin-S tablets with Erythromycin Stearate. 
3. Thromycin oral suspension. Its composition is of 
Erythromycin Ethyl Succinate USP. 
A unique feature about profile projection is that their 
profile has been interlinked and in enhancing one product, the 
other product is also promoted. 
Technical Profile of Thromycin: 
The drug erythromycin estolate is not destroyed in the 
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gastrointestinal tract by the action of acids. The absorption 
of this drug in the small intestine is better than any of 
the other salt and the drug is available in the body for a 
longer period of^time and that too in high concentration. 
Signs of liver damage, indicative of cholestatic hepatitis 
and jaundice have been reported in patients receiving erythro-
mycin estolate for 10 days or immediately on starting a second 
course. These hepatotoxic effects appear limited to adults, 
Thromycin (erythromycin estolate) is one of the macrolide 
antibiotic effective against a large nxamber of organisms. 
Technical Profile of Thromycin-S; 
The drug erythromycin sterate is destroyed in the gastro-
intestinal tract and it is therefore enteric coated. The coating 
does provide sufficient protection frcsn destruction, but it 
cannot be an absolute protection. 
The absorption of the drug in the small intestine is in-
adequate partly due to the enteric coating and partly due to 
the nature of the product. The absorption as such is not 
complete and certain and the administration of this drug does 
not cause cholestatic hepatitis and jaundice. 
Technical Profile of Thromycin Suspension; 
ThrcMBycin oral suspension i.e. erythromycin ethyl succinate 
USP is specially forroulated tor use in children. It is easily 
reconstituted into a pleasantly flavoured palatable suspension. 
This is well absorbed "following oral administration particularly 
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when the stomach is empty. Peak blood levels can be achieved 
within 1-2 hours. It is well tolerated. 
From the above, it is clear that both these products 
have conflicting profiles. The positive attributes of one 
are not present in the other and vice-versa. The potency of 
thromycin is reflected in the USP.,"the Erythromycin that still 
the key antibiotic for certain infections". And thromycin-S 
as the safe erythromycin. 
It is generally propounded that thromycin should be 
recommended for severe infections and thromycin-S for milder 
infection and thromycin oral suspension for pediatric purpose. 
But IDPL people project these products in an entirely 
different manner. They tell the doctors that in either case 
(i.e. severe or mild) thromycin should be administered in the 
beginning, so that most of the pathogens are destroyed. And, 
since thromycin is available in the body for a longer period 
of time and that too in high concentration, it is best to 
suppl^nent thromycin with thromycin-S in the subsequent stages, 
so as to prevent Cholestatic hepatitis and jaundice which may 
arise otherwise. So, here Estolate is the potent actor and 
Stearate is the soother. The linked profile takes the 
products in their totality and combines the merits of one with 
that of other to provide a total treatment for the patient. 
A doctor would highly appreciate this sort of a projection 
and would readily recommend the use of these products. It is 
like hitting the two targets with a common arrow. 
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E R Y T H R O M Y C I N 
THROMYCIN 
T A B L E T S - P A E D I A T R I C SUSPENSION 
STILL THE KEY ANTIBIOTIC FOR 
CERTAIN INFECTIONS 
® 
A T Y P I C A L P N E U M O N I A 
Erythromycin is usually most effective in 
the treatment of atypical pneumonia caused 
by M. pneumoniae as this organism is very 
highly susceptible to erythromycin. It 
reduces the length of illness, and duration 
of fever. In addition, the rate of clearing as 
noted in the chest X-ray is accelerated. 
STREPTOCOCCAL I N F E C T I O N S 
Most streptococci are highly sensitive to 
erythromycin. Hence, in streptococcal 
tonsillitis, pharyngitis, laryngitis, scarlet 
fever, and erysipelas, erythromycin 
provides excellent response. Pneumococcal 
pneumonia also responds promptly to 
erythromycin. 
S T A P H Y L O C O C C A L I N F E C T I O N S 
Erythromycin is useful for the treatment 
of relatively minor infections caused by 
penicillin-sensitive or penicillin-resistant 
Staph.aureus. 
D I P H T H E R I A 
Erythromycin is very effective in eradicat-
ing both the acute and chronic diphtheria 
bacillus carrier state and is recommended 
as the drug of choice for eliminating C. 
diphtheriae from carriers. 
W H O O P I N G C O U G H 
Erythromycin can prevent whooping cough 
in susceptible individuals who are exposed 
to the disease; and, if administered early in 
the course of whooping cough before the 
paroxysmal stage is reached, erythromycin 
may shorten the duration of illness. 
L E G I O N N A I R E S ' D ISEASE 
Clinical experience and the results of labo-
ratory studies indicate that erythromycin is 
the most active antimicrobial agent avail-
able against Legionella pneumophila. 
Erythromycin is, therefore, the drug of 
choice for treating pneumonia due to the 
Legionnaires' Disease bacterium. 
T E T A N U S 
Erythromycin is valuable for eradicating 
Clostridium tetani in patients with tetanus 
who are allergic to penicillin. 
SYPHIL IS & G O N O R R H O E A 
Erythromycin can be employed successfully 
in the treatment of early syphilis, and 
syphilis during pregnancy, in patients who 
are allergic to penicillin. Erythromycin may 
also be useful for disseminated gonococcal 
disease in pregnant patients who are 
allergic to penicillin. 
H O W SUPPLIED:Tablets, each containing Erythromycin estolate equivalent to 250 mg 
Erythromycin, in strips of 10 s; Paediatric Suspension, each 5 ml of the reconstituted suspen-
sion containing 100 mg Erythromycin (as Erythromycin ethylsuccinate), in bottles containing 
powder to make 40 ml suspension. 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A Govt, of India Undertaking) 
P. 0. Box 3816, New Delhi-110049 
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bacillus carrier state and is recommended 
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diphtheriae from carriers. 
W H O O P I N G C O U G H 
Erythromycin can prevent whooping cough 
in susceptible individuals who are exposed 
to the disease; and, if administered early in 
the course of whooping cough before the 
paroxysmal stage is reached, erythromycin 
may shorten the duration of illness. 
L E G I O N N A I R E S ' D ISEASE 
Clinical experience and the results of labo-
ratory studies indicate that erythromycin is 
the most active antimicrobial agent avail-
able against Legionella pneumophila. 
Erythromycin is, therefore, the drug of 
choice for treating pneumonia due to the 
Legionnaires' Disease bacterium. 
T E T A N U S 
Erythromycin is valuable for eradicating 
Clostridium tetani in patients with tetanus 
who are allergic to penicillin. 
SYPHIL IS & G O N O R R H O E A 
Erythromycin can be employed successfully 
in the treatment of early syphilis, and 
syphilis during pregnancy, in patients who 
are allergic to penicillin. Erythromycin may 
also be useful for disseminated gonococcal 
disease in pregnant patients who are 
allergic to penicillin. 
H O W SUPPLIED:Tablets, each containing Erythromycin estolate equivalent to 250 mg 
Erythromycin, in strips of 10's; Paediatric Suspension, each 5 ml of the reconstituted suspen-
sion containing 100 mg Erythromycin (as Erythromycin ethylsuccinate), in bottles containing 
powder to make 40 ml suspension. 
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imGiomn 
Capsules and Liquid 
THE BALANCED HEMATINIC 
Most patients complaining of symptoms like general weakness, vertigo, headactie, * 
something In the visual field, fatigue, dryness of mouth, irritability, amenorrhoea, low 
grade fever etc. etc. may be simply suffering from anaemia. All the above symptoms 
could be the presenting features.' In all these cases anaemia could be due to:^ 
- Excessive blood loss 
- Dietary deficiency of Hemopoietic factors 
- Sequelae of chronic infections like malaria, and tuberculosis 
Be it due to iron deficiency, dietary deficiency, pregnancy and lactation, the defi-
ciency encountered during early childhood and adolescence. In all these conditions, 
IDIGLOBIN plays a definite role because it has all the Hemopoietic factors In an easily 
absorbable and well tolerated form. 
Following IDIGLOBIN therapy the hematocrit values begin to change right from the 
first week of use. 
IDIGLOBIN thus offers a rational approach for the treatment of anaemias of multiple 
etiology. 
- Intestinal Helminthiasis. 
- Prolonged periodic bleeding in women with Endometrial Pathology. 
- Bleeding from Peptic ulcer and Haemorrhoids. ^ 
- Bleeding gums. 
- Chronic Renal diseases. 
- Post operative conditions. 
- Malabsorption syndromes. 
- Chronic debilitating infections. 
- Pregnancy and lactation. 
- Following child birth. 
IDIGLOBIN is well tolerated. 
Available in capsule and palatable syrup forms IDIGLOBIN is presented as' 
CAPSULES LIQUID 
COMPOSITION Each capsule contains. COMPOSITION ^ach 5ml contains: 
Ferrous Fumarate 300mg Feme Ammonium Citrate 225mg 
Cyanocobatamin lOmcg Cyanocobalamir^ 5mcg 
Thiamine Mononitrate 5mg Thiamine Mononitrate 5mg 
Riboflavine 5mg Riboflavine Pliosphate (Sodium Salt) 6.85mg 
Nicotinamide 50mg Nicotinamide 50mg» 
Folic Acid 1 5mg Folic Acid Img 
Ascorbic Acid 75mg Alcohol 10% VA/ 
PRESENTATK)N: Hard gelatin capsules in bottles of 30's and 10O's. Liquid in bottles of 110ml 
DOSAGE: Usually 1 capsule a day after meals or as directed by the physician 
Liquid- Usually 1 teaspoonful a day after meals or as directed by the physician 
REFERENCES: 
1 Clinical Haematology in Medical Practice, G C deGruchy, 3rd Ed (1972) Pages A7-51 
2 Mansons Tropical Diseases, 8th Edition, (1982), Anaemia m the Tropics, Pg 22-?3 
(ffi) • * 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A Govt of India Undertaking) 
P.O. Box 3816, New Delhi-110049 
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Methyldopa Tablets 
FIES MOST CRITERIA OF^  
EAL ANTIHYPERTENSIVE 
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory. 
Emdopa 
Methyldopa I Tablets 
SATISFIES MOST CRITERIA OF AN 
IDEAL ANTIHYPERTENSIVE 
EFFECTIVELY CONTROLS BLOOD PRESSURE 
Methyldopa (EMDOPA) is highly effective in all grades of hypertension — mild, 
moderate, and severe. After a single therapeutic dose, the maximal hypotensive effect 
IS achieved between 4to 6 hours, and continues with diminishing intensity for as long 
as 24 hours. Methyldopa (EMDOPA) effectively reduces blood pressure when the 
patient is recumbent as well as in an erect position. The drug satisfactorily controls 
arte^^al blood pressure during exercise. Therapy with methyldopa (EMDOPA) 
effectively controls blood pressure over periods of 10 years or more, with only 
moderate increase in the average dose needed. 
FAVOURABLY AFFECTS THE VITAL FUNCTIONS 
During treatment with methyldopa (EMDOPA) the vital functions of brain, heart and 
kidney are not only not compromised with, but may be favourably affected. There is 
no risk of cerebral haemodynamic insufficiency and, on the contrary, cerebral blood 
flow may increase. Methyldopa (EMDOPA) decreases peripheral vascular resistance 
without affecting cardiac output, thereby reducing workload of heart. The drug also 
increases myocardial blood flow with significant decrease in coronary vascular 
resistance. Methyldopa (EMDOPA) maintains or increases glomerular filtration rate 
and renal blood flow in hypertensive patients with normal or impaired renal functions. 
DOES NOT PRODUCE SIGNIFICANT ADVERSE EFFECTS 
Methyldopa (EMDOPA) is well tolerated by the majority of patients. Significant 
adverse effects have been infrequent and do not pose a serious problem. Clinical 
orthostatic hypotension, and post-exercise hypotension with methyldopa (EMDOPA) 
are uncommon. Drowsiness, lethargy and dryness of mouth are the most commonly 
reported side effects of methyldopa (EMDOPA), but these subside on continuation of 
therapy. It is after 6 — 1 2 months of therapy with methyldopa (EMDOPA) that some 
patients may develop direct positive Coomb's test, but haemolytic anaemia is rare. 
Drug-induced hepatitis and drug fever are infrequently reported with methyldopa 
(EMDOPA) therapy. Methyldopa (EMDOPA) is relatively safe when used during 
pregnancy as it does n'ot give rise to unusual adverse effects. 
CONTRAINDICATED IN VERY FEW CONDITIONS 
Unlike beta-blockers methyldopa (EMDOPA) is not contra-indicated in hypertension 
complicated with cardiac impairment, A.V. Conducting defects, Raynaud's pheno-
menon, asthma, or diabetes. Active hepatic disease, such as acute hepatitis and 
active cirrhosis, is a contraindication for use of methyldopa (EMDOPA) The drug is 
not recommended for patients with phaeochromocytoma. 
H O W S U P P L I E D : Tablets, each containing 250 mg methyldopa, in strips of 10's. 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A Govt of India Undertaking) " 
P C Box 3816, New Delhi-110049 ~ W 
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A i M A P " 
TABLETS SUSPENSION 
The ideal ontdcid 
• EFFECTIVE ACID-NEUTRALIZING CAPACITY 
ALMAGEL contains two gastric antacids—Aluminium hydroxide and 
Magnesium hydroxide. Aluminium hydroxide provides persistent acid 
neutralizing action with demulcent and adsorbent properties. Magnesium 
hydroxide provides rapid, prolonged and high acid neutralizing capacity. 
The combination thus provides prompt, potent and persistent antacid 
action. Further, the fact that products differ with respect to antacid efficacy, 
according to the process of manufacture and to age of ingredients.is also fully 
taken care oi in case of ALMAGEL. ALMAGEL, thus, has effective acid-
neutralizing capacity. 
H DIRECT ANTIFLATULANT ACTION 
ALMAGEL also contains Methyl Polysiloxane, a powerful defoaming agent 
which reduces the surface tension of gas bubbles and causes them to 
coalesce. ALMAGEL, thus, prevents the formation of gas pockets in the G.I. 
tract thereby providing direct antiflatulant action. 
^ NO LOCAL OR SYSTEMIC SIDE EFFECTS 
Both Aluminium hydroxide and Magnesium hydroxide are nonsystemic 
gastric antacids and thus ALMAGEL is free from systemic toxicity. Further, 
in combination, constipating effect of Aluminium hydroxide and cathartic 
effect of Magnesium hydroxide are neutralized by each other. ALMAGEL, 
therefore, does not cause either constipation or purgation even on 
continued use. 
H GOOD ACCEPTABILITY 
Both ALMAGEL tablets and suspension have been so formulated that the 
effect of the inherent 'chalky' taste of the antacid ingredients has been 
diluted by using propedy processed ingredients, and appropriate flavouring. 
ALMAGEL is, therefore, readily accepted by the patient. 
DOSAGE: The usual dosage is one or two tablets/teaspoonfuls four times daily, to be taken after 
meals and at bedtime. The tablets should be chewed. 
COMPOSITION: Tablets, each contains Dried Aluminium hydroxide Gel 250 mg, Magnesium 
hydroxide 250 mg, Methyl Polysiloxane 10 mg; Suspension, each 10 ml contains Aluminium 
hydroxide Gel 250 mg, Magnesium hydroxide 250 mg, Methyl Polysiloxane 50 mg. 
HOW SUPPLIED: Tablets in strips of lO's and Suspension in bottles of 175 ml. 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A Govt, of India Undertaking) 
P.O. Box 3816, New Delhi-110049 
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory 
CHLOROQUINE-IDPL TABLETS 
Fights malaria successfully 
Malaria has once again been on an increase in the 
country. From 50,000 positive cases reported in 1961, 
the figure has reached gigantic proportions — 
5,000,000 cases in 1975. It is expected that in 1976-
77 incidences of malaria will be still higher. 
Malaria can be successfully controlled by CHLORO-
QUINE-IDPL tablets. CHLOROQUINE-IDPL is an 
effective agent against all forms of malaria, and the 
treatment of choice for all forms of malaria during 
the acute attack. 
DOSAGE 
^ A single dose of CHLOROQUINE-IDPL tablets is 
sufficient for the clinical cure of malaria. 
Dose Age group 
0 - 1 year 
1 - 4 years 
4 - 8 years 
8 - 1 4 years 
14 years and above 
HOW SUPPLIED 
CHLOROQUINE-IDPL tablets, each containing Chloroquine Phosphate 
250 mg., in boxes of 25 strips of 4 tablets each, and tins of 500 tablets. 
Chloroquine base 
75 mg. 
150mg. 
300 mg. 
450 mg. 
600 mg. 
Tipty stomach. 
(Source 
Tablets 
1/2 
1 
2 
3 
4 
; NMEP) 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A GOVT. OF INDIA UNDERTAKING) 
N-12 & 13, South Extension I, New Delhi-110049 
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fr«4ry to accept malaria as a fiaet 
11 ,ef life anii take qinntne and 
M lEfiepaerine tablets as a precw-
4ip •bonarv mea3a'"e 
Vet The Boefeefeiier fDundattoa 
ttng>^W9iacl) lUOCttosiCd Kt OOfHlfffl* 
CH.1 
You Said It 
r„„.-v.oT •fantS-t'TlfTHS' 
fbfic' 'anV tfec " " ^ ^ r n i t ^ n f 
.Id know IS that malaria 
id -^H I would 
' 'BtlOl 
- <n twd ferewi t>rii«sM V * W « ' " J h ' i 'v'-at i T f ' * | li^ V-. 
^he !i{tnl»f* iW-ilib fl*« t * i>?av^ ratrrfait.itt )yl> a i d 
rented its- fti i«i3" A i m m ' / . *. 
"Draper spr \ihg'. Tft«*.i»Tne'i - tfin h r « f «yaw 
tMlmt the -1 Kria were «pOf»ed ft wn J tJhpi r BiU 
rt. ( Ti Chhotj Agpjr !-,« ai»il Bhar ip f .t •.tiiLi A 
P h * r B coniHrstiveij free ' "" ' 
SeptemOer 13. 
'ihir KMtt'a 
^emher 13 U ) , 
d fffirent 
... Here the VOftr 
for carrying the 
(AHOipheUi* 
ci^tm^ ilk 
:Olci ^ ^ H i c e h 
«*iai! 
rampant in Mewat 
.. . urgemiy I^  •» 
[e la the attitude of the citj-
ho neglect to taire any 
YouM etc* A. S 
Jjp^mt'.e pchtoi de«d 
I'j' u<^ 
Hf 
(-f 1 W 
B) 
1 S -
L A / M A H 
tl IJ^J-' " 
- .'2 TrT -P .*«! 
"^^^ 
!9 * iSS-
tmdv ili( ifv ftp voo 'vhotrld 
spprcintc I IR Tail thai tfetv 
keep (he cti> ckan a* IcaM 
once m a way' 
ers 
lalaria 
losing 
this «utuflin to rata 
to tig^l malsr a 
Pfof Sune jBery! 
over S 20 millit« 
Toem of Sw(tji.n 
. . ,. _ most dctdfy »«i 
wtOESpread ol 81! mfectiota dteaeases 
tffliciuig inaiAind today In pans of 
TTwitaad 80 per e«nt of hospttat 
beds t^erB occut»«t &y mafana 
pftuems 
M»larta k Us amflittf)' sbnm I mil 
iion cfeifdren tiftdCT five years of age 
m Afnca he (aid 
J Acasidioj lo the Dlrtteot o( WHO's 
J Bialana and para-siue di^eaws depart-
I Bmnf Pr«f Tfhctr ttSPW D^ilana « « « 
worsentd throughout the wortd Ja« 
year TTae problem was not that new 
Weos had bewn affeaed but that tha 
I Slsease bad taksi* n sif^Bger ho! I w 
rtjpoas where « tmsted 
I Thft human body hart dcvcropcd a 
'Wtstafve oyinst ann nwiana drug, 
and mire research wa» needed mio 
new wayi of comfattng tlw dtwase 
Prof BengSson of Sioekholro t ep . 
cemtc umt recalled that m tha pa« 
decade, 2400 000 anti malada drags Had 
been fejied tn the I titled States. 
A rwHsercb propamnw woutd a a n 
flfcit October in tibena, w«tem 
Mr N T ir a t-iaifimi 
ih i; iJoJYi ne* a^Cft* t 
.^f* 'i > ti- I^kso Shmahft add 
l«T^ ' om t 9 » to i*}-)' -whet h*-
pUMt K njn at j[s fomdiHiOB Sfie 
fnrid ^^ar ft 
He >a^  kveOos -it or'r-chtrf 
d t r •• J JWif a «*T-i s depart 
i>«\t »i i.>r tn r i rci-toi bifotc 
Ertough 
antI - malaria 
stocks: IDPL 
SU^TICGCNT stacks <rf «ad-mal»> rial cbrus? aro oow «MUabl« 
' to meet f&c cttaUeago D( iawlarUt 
i^fUda ) vjdespTMd 
parts t\i ih» cottniry. 
l%c biatoownad iptttau Drtiga 
d fhanBaeetitiM^ Utoued 
lUPt.) IS ntiw fully iicaced 
".leei the oour4.ty's requlrtfrneiits 
o. antimalarial drugs, im manag 
1 :: director I ^ L K B ^ l lOJd 
'romacHar on Wedoeadav 
Itj^: . '* Hydepabad plans is ^ 
rnesent woritutg on a war foot 
1^:; to produce tb«se drugs ou a 
t w i ^ v a soale. 
Dr BeU cald seveiral hundred 
ntflUon taUets of antl-isalanaj 
druaa prodocsd by n>PL fcad a t 
ready been nisfaed to Govern 
roent hospltaJa WKI dKpeii^anes as 
'^;:p]! as pharmacetttlcal trade all 
over the country to contf>.it tbia 
disease. 
Ami Rulazial drugs av^latrie 
ihis year vwtld be about 400 ton-
ttes a« against 300 tonnes avad-
nblo last y o u ; accccdlng to Dt 
]>r Behl said IDPL fetd wrltteai 
o fid State GOTemroeni? public 
l>Mlhl^^llAfnUm and uado <«an-
_ _ _ef a! 
nvil; 
n ) p ] _ 
tmk luMg 
tog way 
Wnistry. 
CatrripoBdtnt tlie proplijlactt- prcgrama>e i\ Vf 
', led 1^ laorf. ciiie-, bcinj ipp rifti 
Metiifca! OfTa"- t-r 
I ana ttie Di^i jci M^ls 
, tlM ii\X •» t \1 i 
number aj ^^UMW 
. ,. i Ii-oa™|ftldiPar«Wlt i P m F bwjnlfclnlfiWed radical trc I. 
'•trldabad C'^ 'npleK and ttie educa- mens agains maiarta and not a 
SoiHtl .Bvi'-ifitns 1 the itti^rlor wn«te patient tiai; died tii* to cnai -
Bdleate- ' 6 ea'lv n le pe ceoi tta 
i^ f *Iie 'a \ i'-di . ' 1 e<;i.ij i l e anah i e expe-^s trom UiP Sa 
manber o ' K^OOI eo -^ (f- n e n tonal Malana Eradi atioi 
«rU T i " riim^-f of SJCI paHfttjlo are vjslttn|[ M«w«t next Ui«a 
*a« slmo*t h».f last jear t, u i s *.3«BS tiw adilevemenL on nie tna * 
«, Jlttle < \tt $j\ pf' cent 0)1 Sep tia control {«ni pam-ntartj iti 
teBjt»r 15 ]a6 the potkets ^m-p-ed Ijj h t VVIiO 
The Heilth ivittioritw^ ttPfe do j^jonwren pllo pi'Ojeet 
n&t dhpuf* thii *he number ot Cxpert-K ha^e dia^no est tiJiu) ype* 
podtiv* mitnna t-i-wi reported a »f nia'arw U' Mewat — one i." 
50 odd eiaiaj-ta con'ro! cerfcres- ft^-^ Plaamadiuni \'i/ax <*-iwcO Is m-'cv , , • , j 
increased by atjcm 40 per wtnt this -atwanion) a rd the oth^r n Plasma- «'^«-^ ^™ pharmaccuucal goods 
ft ^-ns LO'-iitei- and bad hrtii found 
,tii he harnii'td t" Ji^nuri' Re 
•iCrtah ^ IS 9 w hting twdii-ted 
to ftnd ^q tii<rct*cid<. ctiit tviijld 
be cheaper jud jsot harm(ut 
The mmtst r informed the 
It se thj{ do dCTth irom malmfl 
^tL( been Kp"»ued so Cai Mf 
firi d sa d (hit there hsi been m* 
d i p in the mafana eradication 
!^ttmp-«ttn 'Shiyt 2 ^ 06 woikcr'; 
wfre on (he lOb t ' p to Seprtm 
^cr ti U'*! ihe niHTibcr t»f c jy^ 
ported w«s ; 4 ^ i " 0 This 5fim\ 
et* ri definite deetme 
Ihe h M>.e pav^ed supple mem a rv 
krtia *ds tdialhnj^ Rs "^ ftS c t o r c 
thi, (ind< i i^ u needed foi appoi It 
ncr t of 4"'^ m\v pat larrCs Id » -
i.K-)-;e (he phcc lif hnd re^Cfitti. 
1. iltttti in ard pvi-.<*itnt! tCQUir.J 
t ) dmbjtrgv iht ^vti (,i u d rcut t up 
f OiTi iht. I rban Land Ceiliiigs \ t i 
l i d tht. Mttniv fenders Ka and 
(iv meet Ihe state goveutnunt ^ 
*liare K\ Ihc buds i'' of the Tnbal 
\it.*^ IX, tkipmenf Corporation 
ajid th« Rala^t^^an Dawv Develop 
ment toiporation 
Siamrae iNJtEP> (low Sew DpfHt M the hou« the RBt«Mbatt t o n 
t n^coi V P jod J .^nii «dfnent^ fljif 
M^t.'? to utcrcate ihc fund from 
R' ^ crore^ (1 R' 6 croref The \ 
RajaUlun h^Sts l a ^ tAmendment) • 
Bill sti\^ to rcpUtc V(i Ordinance 
)i icmovfi^ tcihmcat iacmtae in 
in posed iin nt-dfCJOes 
CE] 
*«*r M coinpaK'd o !a.st jesr Tlie dium Palflj-^at^m rof «hi h onh 
incidence is ttilJ h gfier in th" casp- tew cajes oc^u* btt wir h i n- > • 
o* Mewat. contprliinj "psioz«pur sever*) Tlw Isttcr 1 
J h rka snd Snh '-ub d» i3lon compsmed bi c 
Offlctala bow-tvM do itut «it"-e etftidU-v i t d tr.. 
that "mere IncwaM m tha num^ei 'tic fl-rst time i\ 
e ' poslHws cases repoil*d Bwa-e o i 'ieM r-'^  
Sr.cr»aa«l incidence" Inten-Mve an i \ o-iw 
pnflMiiged eampRisni oi collectmi Men-t n 
blood i!Jde« of fhe msxinnim ii-m *;amijaiw, 
ber of pwsons auffwint: tr«n fe^w and a b i i r t 
towlvtn? both the Mimmunl ^ an-l f*vfr t nd p 
the lota! priva e T-a^tMnex* oi<l«r longei 
Reasons for setback to 
anti-malaria drive 
6 j Our S^ff Correspondent 
fsmmu rcgi >n ff Jaramu and Kasb» 
T 
I Odjtvf 
tiinnu 
(feaths 
'^ "dch , 
r.A>wffl!iy of djo wtaarv. 
Tho sKggetmg rise in flu In-
SRINAGAR, JteWeipber IS. 
THF mtffibec of detected tnalant CHMs iiKteawd Ilonj 60,t)0ff m 
t*i&2 to t,322«M m 1971 and to neatly 
AMonfinis to a Vnron government 
nifion to the 2?ih sesiiwi of tha 
WHO rejpoi»*i commtttae, now tne« 
mg here, the maJunat mo«|uito bas 
devc iped icMstanc* to DDT m Gajt 
rat Mahara«hna Rriaxtbaft and « r 
Visa pockats in tJ P feawr and this-sa 
Va* makria earner h«t aho devc 
kroed iBimuoHy to chcmwal^ it«d foi 
dWlmj! w^h W in fls* wiban »«as 
6f ^T^dhr* pradteh-Tafwl Nadu Kat 
nwaka (.misMt MaRaia^hira am! die 
Communities 
to help 
g)mbat malaria 
if*""' 
W l ^ * a t l 
m g w H a w . . -_ , 
hiaited ft Vitsfr expenmenE to gl** whrre'the fnattefice of otalana 
a maarfve tiirust to toe nation wJvtv pnued to be hiab 
CHinp«Stn agalBM. maUil* UBEJE TIJ^ tnalarra problem h cau^'nt 
wtty partic«)aUQn m tOe conitol •• «u^ern to the iovwmnettf F\t«MJvo 
ih» duKfiiW Uad« tUe new acheinc n^j,,,„M aw being planned to fluhl 
voluntary agencies studentA_»na , „ wobtem One thonwnd rmJii .n 
youtb oi^anis^tana MU stipffletoeai, „u^,„e cupsalw have been h««(ibi 
the govetnmeaaal eSttrta B*eady un- ,f,^ i rNirEF h^^ amEtt«i to India 
der way to coaibat. nWi^ia j - . ^ nuirKwi ca " 
~ g b « ~ - ^ 
'Iffioag ifte iBB'iiiWt^  IiMed lof the 
setbadt to the raalatia entdicatwn 
proaraifime were &e rnctea'Jn^ c i " 
i»f insectierdei non-avaiiabifctj- of che 
xm.%\% ttwd ift the «fadicafon dri-vfi 
and absence of measures ter segrega! 
MUt majana CBAW lo hospitals SiOil 
ai^ of veHltles for ihe ptci;^amn» 
i*a< also responsible f t affefctiag th* 
Kitbt agatittt ovdana Mapy itepit and 
•laiidfovetf, deployed for ftsdijing mala-
ria oft asvwaf footing ID the fiftiei 
wrrc fatSttit a ^ t t 
J atcly thfcre Iwd bean a eoosidei' 
able increetse ttt malana «ase« in tidwo 
KfM where, for vaiKius reasonSy tha 
fmtife aipiinsit tfw tnogqujin Vas not 
eft-¥ o •wat*f l-Bboilrer? from dtSe-
n-ni pam of the «Rji>lry came loae 
ifefti j« large mtnaberi for workmsj 
t^ n projectj bfce hvdct dam^ As aj 
re*ittt ih*i Bpffcad of the d neaw from 
one area ta anorJwr had bacome Msier 
The ffpravrng of m^eciitides n 
malaf!»rtddeo area^ M-b^ peopt] 
nk.staftd their h o n ^ •f^^'mA h; 
Malaria cabes in 
Visakliapatnam 
VlsAKHAPtTNAM Sept i*i 
s.imachari—Aljoat 70 600 peoplt 
m the agemj areas ot Vjaakha 
nmn dihtnct are buffering [mm 
] .ii-a accftding \n a spoktsmaa 
If the !En*a pan^a t l here 
The IncidiBiM'' It said to he 
i,h(r in the lOttrwr tnba! vltlagM 
diintapaili and Padcru talnki 
The spol.«sman said the «ftis 
wrishad had ptHchs'wd Rs 5000O, 
^ I'h of drugs to he dfatrltnif«r 
»} Jhe- affected peopNt 
m addition to t^ »? existing mala 
rtri staff of the drs'rict n>odIcal 
«id health office about 280 tea-
ciiPFs o"" the lilia pan-shap had 
iwn •!,-\\fiti trstnitJK for conduc 
tiBi. tiirvei lance work and dlsfn 
DH on <il drucs to tha a^fft^td 
people he s-an' 
All-out war 
on malaria 
Tie na i m-wide t^trnpafga 
a'li^t malaria fs he.ng given » 
V thrust thrtshj^h eomtni>ti«> 
jtiuon m t^ ^ *1 t*' 
he disi-ase reports ^amachat 
L'-J r hs new seh^m- 3 
I iqtte eM> nnKi r in the spi t^ 
<f Belf-h*.lp vnnntary aginci**- l i i . i^i^«^ 
•tL udma 5-1 idcH'- and *. itt'h or 
3?^ti!=ations are to suppl'nienf 
'*ie masM^ff gov 'mmental effort^ 
r ' dv n d - " vav ' comba 
vii 1 w\ ' i an official press r* 
Voiunjrv workers have been 
i i ' f <'() on an espmaaenta! 
m 'wnt* pai^5 of the coun-
iindvratce ns'Ctlf ila 
. ^ i 
\ 
1974. 
wrattted for « ^ per wn t of 
nulai ia eases nwwrted dar lns 
1975 Malaria eases ((timed rWng 
rapidly (ovarda the end of last 
year. The disease has now be» 
co«« a maior public braltb »«(>• 
lem m njost of the States. 
Car for Sm cases 
of sferilimtmn 
t ( t K N O W , tMob«r 5 
tHdmaihurl fbe dltlricl maiti* 
^s ar^ 7 533-
last] 
.r -T h 14 
bo«- The luecess of hl« firs*t 
n(penm<m led 'o the laonchtnffi 
o' i^ imilar opefanonF 'his year 
1 "he t <,-o nalehbourtng block' 
of r-iroo and Chandta 
dtatri 
9^ per cent ol the 9740 Houses »nd ?««*• 
505 cattle-sneda wei^ sprayed last 
sear aolelv througSt -votunfiary laUotw 7 6 0 r h l O f l C e l ^ S 
This yeei it w belnK dooo In twn 
leigtitoounn* blocka Oaroo eniJ C O U I l t r V 
ChawUa. 
likely 
vo TiaiBii'JMwriiig uit«.-n.-
and Chandla ^ ^ ^ R j 
in India 
In Alwar dtetrict of fa ioauup, 
i ^ a y m g operationB *fcie qairted ous 
tl^s ye«r by the local students durr-
tag ttte vacatioite under t t e HMEP 
ataff The prograflaWft was nJawnea 
-^* ttj t l » help or th« Eftatnct Inn-
iwctor of sehoola and tbe Prinfflpal 
of tjie tocBl HtgflBf jSeccawawy 
ai-Kinl TVnHtiir flwi i«vBnU«f> a. HtTarare 
Vt h s 1 i.1 pffievtfin the pi^ptilaiim 
(i ihe Indwft fhtrwcei n has usen to 
i^-iut Wl Kdiv hem barftv j l^vrn 
'T iCjr^ . io *orid WK! We fund 
In I t ^(liHn «ai!t b«e toliv 
The tWKe-i lisW Ssmdch i thi 
ilip In l a r ihin" *hnh enve had it 
impresi^e n n ^ ot hAhi'at from * u 
1 row Pakmil thioiti,)i ihe If Ij 
SRINAtiAR September 16 tSJita-
dwr) The estabRshmatl of a malana 
eradicaticfio iramfOs msntuie for Souih' 
fast Am it»i been proposed by Ifldi* 
m a draO resolution gahtnitted to the 
World HcaJih Or»tn»tKa>s regional 
ftommiuee fio-* m aeMiaa here. 
ComwHw sources sard the propoKd 
tn>n*Bt« was iiltftly 10 b« located vt 
In***, A( oresenl wodttrs for Hoi 
7in oc 
KtKHip 
*<th fiC 
KlNM 
Gebexiri 
(Vit. B Complex+C) For Therapeutic use 
THE NEED 
THAT HARDLY 
MANIFESTS AS DEMAND. 
THE NEED 
FOR VITAMINS 
For the use only of a Registered Medical Praaitioner or a Hospital or a Laboratory 
Cebexiri 
(Vit. B Complex+C) For Therapeutic use 
THE NEED THAT HARDLY MANIFESTS AS DEMAND. 
THE NEED FOR VITAMINS J 
Man can neither synthesise nor store to any significant degree, the water-soluble vit-
amins (B-Complex and C). Normally, these vitamins are replenished every day 
through diet.' 
However, in certain situations as in conditions of stress, inadequate dietary intake, in-
adequate absorption and during increased metabolic need, the water soluble vita-
mins may be depleted,^ thus requiring additional supplementation. 
Because of one or the other of the above mentioned reasons some amount of defi-
ciency of the water soluble vitamins are usually present in conditions like 
- Malabsorption syndromes^ 
- During antibiotic therapy^ 
- Post-operative and burns^ 
- Chronic alcoholism" 
- Diabetes mellitus" 
- Pregnancy and lactation^ 
- Convalescence ^ 
- Febrile illness 
and require supplementation of the water soluble vitamins. 
CEBEXIN provides these in adequate quantities. 
Recommended dietary Intake* (Adult) Each CEBEXIN Tablet provides 
Male Female Lactation Pregnancy 
Vit. C(mg) 
Nicotinamide(mg) 
RitX)(lavin(mg) 
Pyndoxine(mg) 
Thiamine (mg) 
Folic Acid (mg) 
Cyanocobalamin(mcg) 
Cal. Pantottienate(mg) 
40 
19 
1.7 
2 
1 4 
0.1 
1 
1 
40 
15 
1.3 
2 
1 1 
0.1 
1 
1 
80 
18 
1 6 
25 
1.4 
0.15 
1 5 
to 5 
40 
17 
1.5 
2.5 
1.3 
0.3 
1.5 
*' 
150 
100 
10 
3 
10 
1.5 
10 
10 
* Recommended dietary Intake forlndians (]981) 
NutntiveValueofIndianFoods(1981)N3tionaltnstituteotNutntion ICMR Hyderat>ad 
" Dnjg and Cosmetic Rule Sctiedute V Propnylactic Range Govt of India Putjtication (1979) 
CEBEXIN Is also available in highly palatable syrup form. 
DOSE: 
TABLETS One tablet daily or as directed by the physician 
SYRUP' One teaspoonful daily or as directed by the physician. 
REFERENCES: 
1 Laurence, D R , Clinical Pharmacology 4th edition, 1973, p 28 2 
2 Goodman, LS andGifman, A PhamiacologicalBasisofTherapeutics, 5th Edition, 1980, p 1557-1558 
3 Conn HF Cunent Therapy, 1977, p 914 
4 Anita, F P Clinical Dietetics and Nutrition, 2nd Edition, 1973, p 465 
5 Seevy, C M and Baker, H , Am J Clin Nutr, 1968,21, p 1325-1328 
6 C Gopalan et al, Nutntive value of Indian Foods, 1981, National Institute of Nutrition, ICMR p.2 
(ffi) ^ 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
{A Govt of India Undertaking) 
P.O. 60x3816, New Delhi-110049 
AMPICILLIN 
Paediatric Suspension 
\ Injections 
500mg Capsules. w^'WlA^ 
250mg Capsules 
THE ONE NAME FOR FULL RANGE 
BROACIi: 
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory 
BROACIl. 
Capsules - Suspension - Injections 
THE ONE NAME FOR FULL RANGE 
Broacil is IDPL brand of Ampicillin available as capsules, suspension and parenteral dos-
age form. 
Years of clinical experience of doctors all over, establishes the therapeutic credibility of 
Ampicillin. As a penicillin congener derived from the penicillin nucleus, Ampicillin has 
proved to have the outstanding property against a wide range of Gram-positive and Gram-
negative microbes including H. influenzae, salmonella, shigella, non-penicillinase produc-
ing proteus, most strains of E. coll. 
Broacil, is 4-8 times more active than that of commercially available penicillin preparations. 
THERAPEUTIC INDICATIONS: Broacil offers a bactericidal remedy against the above organisms often responsible for 
• Unnary tract infection (including infections dunng pregnancy) (Kincaid-Smith, P (1964) 'Ampicillin in bactenuna and pyelonephritis of 
pregnancy , Postgrad l^ e^d J (SuppI), 40, 74) 
• Septicaemia due to Gram-negative bacilli (either alone or in combination with other suitable antibiotics). 
• Typhoid fever and other infections due to salmonella (in Chloramphenicol resistance cases or othenwise) (Overturf, G et al (1973) 'An-
tibiotic resistance in typhoid fever, New Engl J Med 289, 463) 
• G l Tract infections with shigella (Haltalin, K C etal (1972),'Treatment of acute diarrhoea in outpatients Double-blind study compar-
ing ampicillin and placebo, 'Amer J Dis Child, 124, 554) 
• Wide range of respiratory tract infections including paediatric infections 
• E N T infections 
• Others soft tissue infections caused by H influenzae type b 
• Bacterial endocarditis (Johnson, D G et al (1965), 'Subacute bacterial endocarditis caused by Streptococcus faecalis and success-
fully treated with ampicillin , Med J Aust 2, 1026) 
• Infections of the billiary tract 
PHARMACOLOGICAL ASPECTS: Broacil is acid resistant and hence well absorbed when administered orally Broacil parenteral, how-
ever, IS indicated in more severe cases In case, however, the parenteral administration is difficult, administration of Broacil along with Prob-
enecid IS an alternative to parenteral administration The peak concentration is achieved within two hours Doubling the dose also doubles 
the serum concentration 
The drug is bound to protein to an extent of only about 20% the lowest for any penicillin and semi-synthetic penicillin The route of excretion 
IS mainly renal but fairly high concentrations are also found in bile 
TOXICITY: Often skin rashes, gastro intestinal disturbances, some degrees of hematological disorders are reported Only with very large 
doses (intravenous), capable of giving rise to a serum level as high as SOOmcg per ml may cause encephalopathy 
ADMINISTRATION AND DOSAGE: For mild to moderate infections - 50 to 10Omg per kg body weight per day given orally in four divided 
doses The most common adult oral dose being 500mg 6 hourly and 250mg 6 hourly only for mild ambulatory cases with highly susceptible 
organisms 
Parenteral: For serious infections high doses are necessary In children 150mg per kg per day is recommended Broacil parenteral is given 
usually every 4-6 hours depending on the seventy of the infections 
Newborn and premature Infants: Dose is 25mg per kg per day administered in two divided doses for mild infections For severe infections, 
however, 50mg per kg per day in two equal doses is recommended 
Broacil in renal failure: Broacil is relatively safe given in usual adult doses In cases of anuria, however, the average plasma half life of 
Broacil is raised to 8 5 hours In these patients half of the daily calculated dose may be given twice daily There is however the risk of 
increased skin rashes in patients with severe renal failure treated by Broacil Broacil can be safely added to peritoneal dialysis fluid in a dose 
of 50mg added to each litre 
HOW SUPPLIED: CAPSULES each containing Ampicillin Trihydrate equivalent to 250mg/500mg of Ampicillin, in stnps/vials of 4 s SUS-
PENSION each 5m! of the reconstituted suspension containing Ampicillin Trihydrate equivalent to 125mg of anhydrous Ampicillin, in 40ml 
bottles INJECTIONS Each vial contains Ampicillin Sodium equivalent to 500mg of anhydrous Ampicillin 
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A complete range 
to successfully 
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infections 
NEPODEX 
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory 
NEPODEX 
A complete range to successfully 
deal with local infections 
DUSTING POWDER 
NEPODEX dusting powder provides the combined antibacterial 'cover' of 
two valuable, mutually-suited topical antibiotics—Neomycin and Bacitra-
cin, and Sulphacetamide. NEPODEX keeps the cuts, bruises, burns, *" 
wounds, etc., free from infections. NEPODEX dusting powder is indicated 
for both prophylactic & therapeutic use in infected wounds, 'wet' or 'weep-
ing' lesions, burns; dermal ulcers, dermatoses, eczema, impetigo, furun-
culosis, folliculitis, acne necrotica miliaris (prickly heat-acne), seborrhic 
dermatitis and other pyodermic skin conditions. 
COMPOSITION & PRESENTATION: Each gram of the powder containing Neomycin sulphate 
5mg, Bacitracin 250 units, Sulphacetamide 60 mg, in 10 g polyethylene sprinkler. 
EYE/EAR DROPS 
NEPODEX eye/ear drops combine the complementary antibacterial 
'cover' of Neomycin and Polymyxin extending over gram +ve and gram 
—ve organisms including Pseudomonas aeruginosa, together with the 
pronounced antiinflammatory, antipruritic and antiallergic actions of dexa-
methasone. NEPODEX eye/ear drops are indicated for the prophylaxis & ^ 
treatment of infections of eye/ear such as conjunctivitis, suppurative 
conjunctivitis, blepharitis, dacryocystitis, corneal ulcers and various types 
of keratitis, chemical or thermal burns of the cornea, sympathetic ophthal-
mia; otitis externa, otitis media(for short-term) & wound cavities in the ears. 
COMPOSITION & PRESENTATION: Neomycin sulphate 0.5% W/V , Polymyxin B sulphate 
0.05% W/V , Dexamethasone sodium phosphate 0 .1% W/V , Benzalkonium chloride 0.004% 
W/V , in 3 ml bottle with plastic dropper assembly. 
EYE/SKIN OINTMENT 
NEPODEX ointment provides the combined antibacterial 'cover' of Neo-
mycin and Zinc bacitracin together with the pronounced antiinflammatory, 
antipruritic and antiallergic actions of dexamethasone. NEPODEX oint-
ment is indicated for prophylaxis and treatment of external bacterial 
infections of the eye and skin, where inflammation and infection may • 
coexist, as in styes, conjunctivitis, blepharitis, infected corneal ulcer, 
various types of keratitis; atopic dermatitis, dry and scaly infected 
eruptions, furunculosis and other bacterial infections involving eye/skin 
and outer ear. 
COMPOSITION & PRESENTATION: Each gram containing Neomycin sulphate 5 mg, Zinc 
bacitracin 250 units, Dexamethasone sodium phosphate 1 mg,in collapsible tube of 5g. 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A Govt, of India Undertaking) 
P. 0. Box 3816, New Delhi-110049 
NOT JUST A PAIN RELIEVER 
OR AN ANTICHOLINERGIC 
BUT... 
A RATIONAL APPROACH 
TOWARDS MANAGEMENT 
OF PAINFUL SPASMODIC 
CONDITIONS 
^^^HDtOSPASM 
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SPASTIC DYSWIENORRHOEA 0 
TABLETS - DROPS 
® 
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory 
® 
TABLETS - DROPS 
3 way acting antispasmodic 
rrlependent analgesic actian 
h ' Hi PARASYMPATHETIC POSTGANGLIONIC ANTICHOLINERGIC ACTION (Homatroplne Mbr) 
<X1 PARASYMPATHETIC GANGLIONIC BLOCKING ACTION {Homatropine Mbr) 
m PERIPHERAL ANTISPASMODIC ACTION MECHANISM OF ACTION OF SPASMIZOL 
It is the sum total of gentle action on three different areas concern-
ing smooth muscles' activity that makes SPASMIZOL exert POW-
ERFUL antispasmodic action with LEAST side effects. While this 
powerful antispasmodic action relaxes the smooth muscles, it is 
through independent POTENT analgesic action of SPASMIZOL 
that pain—the most disturbing manifestation of spasm—is simul-
taneously relieved. Because of its action on both SPASM & PAIN, 
prescribing SPASMIZOL becomes the rational approach towards 
management of all painful spasmodic conditions of visceral 
organs. 
D O S A G E : For adults, 1 -2 tablets three times a day For infants and young children, 5-10 drops three to four times a day. 
For older children, 10-20 drops three times a day 
COMPOSIT ION : Tablets Each contains Homatropine methylbromide 2 5mg , Analgin 500 mg , Phenobarbitone 10mg 
Drops Each ml contains Homatropine methylbromide 2 5mg , Analgin 100mg , Phenobarbitone 5mg 
H O W SUPPLIED: Tablets in strips of 10's, Drops in 10ml. bottle with dropper. 
INDIAN DRUGS & PHARMACEUTICALS LTD. 
(A Govt, of India Undertaking) 
P. O. Box 3816, New Delhi-110049 
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MEDIA. PLANNING 
In any promotional campaign it is important that the 
various eloaents be fixed judiciously, so that the efforts 
involved are not an exercise in futility. The various 
elements include : (i) Personal selling (ii) Advertisement 
(iii) Sales Prcsnotion (iv) Publicity. The market'eer, has to 
make the proper awareness of his product and even convince 
them about its adequacy. In this context, we can say that 
the marketeer has to communicate with his prospects and also 
has to convey his message in such a manner that it is inter-
preted rightly by them. Media can therefore be defined as 
the link between the marketeer and the prospects through 
which the message about the product i.e. the market profile 
of the product is projected. The message aimed at the target 
can be communicated in any one of the following ways or a 
imixture of the two i.e. (a) - Personal, (b) Non-personal. 
The various elements of the persuasive - communication 
mix model are depicted below: 
Selective 
selling 
Mass 
selling 
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From this, it follows that in pharmaceutical selling, we 
have to concentrate more on personal selling since it involves 
a very limited target. The other elements of the mix holds 
less importance relatively. Publicity here is undertaken on 
the corporate level and is not limited to individual products. 
The following criteria has thus to be borne in mind 
before selecting the promotional mix: 
1. The doctors do not appreciate that the patient should 
also be familiar about the details of any product, 
because otherwise, he may be questioned very easily and 
his reputation put at stake. 
2. Anything which is advertised is not patronised by the 
doctor. Thus, those preparations which are required to 
be sold o'n the prescription of a medical practitioner 
should be exposed through those media only, the use oi. 
which is restricted to the medical profession. 
3. For most of the drug, the law prohibits advertisement 
to the lay public. This is done to avoid wrong use of 
a drug. People do become over enthusiastic about certain 
advertisements, they see and may tend to put the product 
to certain unwanted users. These include products like 
antibiotics, sulphonamides and analgins used for heart 
patients. 
Thus, only those drugs which can be sold without the 
prescription of a medical practitioner are advertised to the 
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lay public. The drugs are called the O.T.Cs (on the counter 
drugs). Examples of such drugs are found in AsprO/ Anacin^ 
Saridon, Paincut, Cinkara, S^fi etb. Such drugs are then, 
not promoted in the circle o^ the medical profession. 
A. Personal : The personal media includes the following 
modes of promotion; 
(i) Personal contacts through sales representatives 
(ii) Medical conferences 
(iii) Seminars 
(i) Personal Contacts j Personal contacts rank the top-
most for promotion ina pharmaceutical concern. In pharmaceuti-
cals, the targeted market is the doctor only and therefore, 
it is important that a drug be discussed with the doctor 
thoroughly, before he Cc\p rec^ ommend it for use. In this industry, 
it is also important to rest^ -ict the media to doctors only, lest 
the layetee is also exposed to the drug. Since the target is 
very limited, it has been a Convention to visit the doctors 
periodically, through the me<aical representatives, who are 
trained to discuss the product. To authentify his statements, 
the medical representatives cjarry the literature in printed 
forms. He discusses about the product, based or all the printed 
material and he leaves a hancj-out for the doctor. 
Training of the Sales Force s 
IDPL also has a provision for training the sales force 
it recruits. They are given -training regarding the essentials 
of creative selling. They ai^ e given them extensive knowledge 
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about the cotnpany's new products and the strategy of promotion 
being adopted for that product. 
Evaluation of the Sales Force : 
Evaluation of the sales force is mainly done by the 
sales they achieve for their regions. E^veiry medical represen-
tative is assigned a target by the regional sales manager in 
' keeping with the potential of his territory. Efficiency of 
the field force is represented in the fulfilment of their 
assigned targets. On fulfilling the assigned targets, the 
field force is entitled to an adequate incentive (generally a 
monetary renxaneration). 
Pre-Platmed Detailing (PPD): 
PPD means, a talk , planned and prepared well in advance 
to be used by a salesman in the course of an interview "with the 
prospect, for the achievement of a specific sales objective, 
A talk has two aspects i.e. "what" and "how" to speak. 
One essential component of PPD, therefore, is the subject 
matter, in the language and sequence, required to be followed 
as such by the detailer, whereas guidelines for correct gestures, 
modulations of the voice and proper synchronisation of the talk 
with the detailing aids literatures, samples etc, forms the 
other component of it. These components together with readymade 
answers to 'effectively handle the questions and objectives' 
which may arise during the interview makes a complete PPD. The 
draft of PPD is formulated according to basic principles of 
selling i.e. Approach, Demonstration and Close in a sequence. 
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In approach/ the attention of the prospect is attracted 
by offering him the advantage he needs. 
In daroonstration, the doctor is convinced that our 
product is the best suited to give that advantage and to 
satisfy the needs. 
In Close the prospect is impelled to act ie.specific 
commitments for prescription or an order is taken. 
Advantage of PPD : 
Phaxnmaceutical selling is a sort of indirect selling 
where one has to pre-sell the product before actual sales/ 
consumption takes place. And the most effective tool to pre-
sell the pr6duct is detailing to doctor. In other words the 
ancher of success of a pharmaceutical organisation lies in 
effective selling. 
Since PPD is based on the ability, experience and infor-
mation of various experts, it is reliable tool and should be 
given preference over the detailing made by individuals based 
on the broad guidelines. 
(ii) Medical Conferences : Almost, in all the disciplines 
of the medical sciences there are All India Associations who 
arrange conferences as a means to exchange thoughts and to keep 
the doctors abreast of the latest developments in that field. 
All the invite^ doctors assemble to exchange views. These 
scientific deliberations are exaggerated, by reading papers based 
on experiments, experience and research. In these conferences, the 
pharmaceutical companies put up their exhibitions, where the 
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products are di^layed, informational literature is given and 
discussed with the doctors. 
These conferences are used to develop a rapport with the 
doctors/ by contributing to the expenses of these conferences 
by hosting Itanches, dinners etc. This i-s also a means to woo 
a way the prospects. 
(iii) Seminars : For certain special products^ the 
company arranges seminars in co-ordination with the various 
medical associations. In the seminar, the entire research work 
on the product is projected by the pharmaceutical concern. These 
papers are read out by experienced doctors in the field or by 
those doctors who have conducted research on the product. 
Seminars are conducted mainly for research products or products 
with certain alterations but new to the product mix. Seminars 
are also conducted for those products which require special 
emphasis in the product mix i.e. for the core products of the 
total mix, 
B. Non-Personal Media; 
This media has the following components, 
(i) Advertisements through periodicals, newspapers, 
hoardings, display charts, television, radio,mailing 
etc. 
(ii) Promotional literature, 
(iii) Film shows and exhibitions 
(iv) Gifts 
(v) Samples 
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Advertising : The function of advertising is to present, 
promote and sell ideas, goods and services. It is important 
that the advertising programme shouldbe in consonance with 
the entire promotional mix. 
In the pharmaceutical industry, advertisements are 
resorted to,mainly as a reminder of the product. The main 
media of advertisement used by most of the drug houses is 
medical journals. In India about a 120 medical journals are 
published relating to different branches of medicinal practices. 
A good doctor likes to go through a couple of them regularly so 
as to keep abreast of the latest developments in the concerned 
fields. It therefore becomes a very good media for advertising 
the product. These advertisements supplements the efforts of 
the medical representative. They remind the doctor of the name 
and salient features of the product during the interval between 
one call and the other. It is also customary, to convey the 
profile through medical journals by getting the scientific paper 
on the product printed in the journal. An important point is that 
all those products which are promoted to doctors only are newer 
advertised in journals having public circulation. 
The major journals in which the advertising is done are 
"Indian Medical Gazette". Journal of Indian Medical Association", 
Journal of Applied Medicine, "The Practitioner", "Antiseptic", 
"Indian Journal of Surgery" etc. A budgetary, allocation to 6 lacs 
has been put forward for advertisement. The company also allows 
the regional heads to give advertisements in certain brochures etc. 
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The regional offices also undertake to arrange film shows and 
exhibitions on behalf of the organisation. A separate budget 
is earmarked for promotions undertaken at the regional levels. 
Mailing : Mailing is another media of advertisement 
used in the pharmaceutical industry. This has, however, 
become reduniant mode presently. All the same it remains an 
effective media to communicate to the prospects about the 
products. Here, we mail the literature of the product as such 
or in short form or in the fonn of letter or in any such form 
to the doctor periodically. This also acts as a reminder to 
the doctor about the name of the product. This media is also 
very helpful in supplementing the efforts of the sales repre-
sentatives. To ensure that the target is covered thoroughly 
by the mailing section, the company maintains a list of 
addresses of the various important doctors and retail chemists. 
The list of addresses is maintained as given b^lowj 
1. In the form of metallic plates, from where the addresses 
can be printed on the mail with the help of a machine 
known as the embossing machine. 
2. Address pulls are taken out from the computer, where the 
addresses have already been fed from time to time. From 
these computers, we can print the addresses directly on 
th#^ aiail to be sent. 
To provide ease in the functioning of the mailing depart-
ment the post and telegraph department provides a franking,machine 
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which can print the postage stamps on each and every envelop. 
Mailing can be (i) of the open type (ii) closed type. 
An open mail goes without an envelop and the address is borne 
on -the face of the literature itself. But a closed mail is 
carried in an envelop. The literature is put into envelop and 
is mailed to the respective doctors. 
Open Mail (Advantages): 
1. It is economical for printing and postage both. Since it 
goes without the envelop, it saves the cost of the envelop 
and also the efforts required to inser-^  each literature 
in the envelop. 
2. Once it goes in the hands of the doctors, he will give it 
a cursory glance, since he does not have to rip open an 
envelop to read the contents. In a way, the doctor is 
foirced to go through that price of literature. 
Pis advantage s; 
1. During transit, the cards may become crumpled and thus 
shabby. Sometimes the cards may be destroyed also. 
2, The message is to be printed on a very limited space, 
therefore it can not be comprehensive. 
Closed Mail (Advantages): 
1. Literature reaches the prospect in proper forms. It doe^ 
• not get crxampled or dirty and thus retains its original 
impact. 
2. A lot qf information about the product can be sent in 
this form. 
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3, A closed mail provokes the doctor to open the envelop. 
He may be curious to find out, what has been sent in the 
envelop. 
It has been found, that the cost involved in mailing 
does not warrant the use of this media. The effectiveness 
obtained from this method does not match with the costs incurred. 
Since it is not a productive method, the companies are trying 
to do away with it. IDPL had a very strong mailing department 
but now they have stopped using this media for promotion,since 
the cost of paper and printing have soared up to new heights in 
the recent past. 
Instead, the companies are resorting to publish some 
scientific material concerning a drug and in this method they 
promote their drugs indirectly. This scientific material comes 
in the form of newspaper bulletin or certain medical booklets. 
In these publications the product is advertised and is sent to 
^ limited number of doctors, particularly to those who can be 
inore concerned with the use and recommendations of the drug. 
Promotional Literature : 
Promotional literature aims at explaining the product 
thoroughly to the prospect. The function of promotional litera-
ture is to highlight the main features of the product, its 
composition, its use, its dosage forms and so on. All this is 
done within the frame work of the market profile of the product. 
It is quite an expensive media of promotion. ]^n fact preparing 
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a literature itself involves a tedious process. 
Cfertain ideas are thought in accordance with the product 
profile and market profile and presented to the advertising 
agency. Certain designs are then sent by the advertising 
agency for approval. The best is selected and sent it to a 
committee for evaluation.They point out the facts which 
should be printed or omitted. The finalised literature is sent 
to a medical committee in order to authentify the facts stated 
in the literature. Their technical knowledge is also incorpo-
rated. This is then finally sent for printing. Generally 
tenders are invited from reputed parties for quotations to 
I 
print these literatures. 
A company keeps changing its literatures time and again. 
The frequency of change of literatures of a product depends 
mainly on its sales potential and also its relative importance 
in the total product mix. The major reasons for changing the 
literatures are enlisted below: 
1. Since the medical representatives visit the doctors every 
month or quarter a year, they present their literatures 
at each visit. It is very likely that the doctors get 
tired of seeing the same literature again and again. A 
new presentation will arouse the doctors interest and he 
would like to see what the company is offering. 
2. When the market profile of the product is changed i.e. its 
USP etc. is changed and the product is given an entirely 
new image, this naturally warrants a change of literatuije. 
i : 1 1 1 i : 
3. Initially when the product is introduced, the incorpo-
rates all its vital points i.e. its maximxam use is high-
lighted. Later on, only a few features are put in the 
lime light, A more specific feature of the product is 
projected, since it 'is easier tor the doctor to register, 
that the product has to be used for a particular disease. 
4. Also, when a particular feature of the product is 
repeated very often, its effectiveness is diminished and 
therefore, it may have to be deleted. 
The minimum periodicity of change of literature of IDPL 
is about 3-6 months. Certain organisations introduce new litera-
ture for a product even after a period of 2-3 months e.g. Glaxo, 
Pfizer etc, 
/ 
Film Shows and Exhibitions; 
Many pharmaceutical companies make certain scientific 
films, where the salient features of the product are projected. 
To convey the product in a particular manner, details of the 
product are shown and its important features compared with the 
existing products. Such films are shown at medical conferences, 
various meetings and also in medical colleges. Films are also 
made by the companies to project the house name though this is 
more of a publicity function. 
Pharmaceutical companies also arrange exhibitions at many 
medical conferences. The products are displayed there and the 
r 
informational handouts are distributed to the visiting doctors-
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and their expert knowledge of the drug is obtained. Free 
discussions on certain products are promoted to know what is 
expected of the drug and what the prospects are actually 
getting. Exhibitions are also arranged at seminars or at 
international and national fairs, where the company wants to 
promote its products. 
Samples : 
It is customary in the pharmaceutical industry to give 
samples to doctors as a means of promotion. Samples mainly act 
as a reminder in this industry for the doctors. Initially the 
samples are given to create an awareness about the products. 
This is however a very expensive mode of promotion. In IDPL, 
samples have an existing budget approval of 15 per cent of the 
sales. Samples are allocated at the rate of 10 percent of the 
target for all new introductions. Later on, when the product 
stabilizes, the allocations tapers off to 4 percent of the 
target. 
All pharmaceutical concerns provide samples to their 
prospects e.g. Glaxo, Ciba, Pfizer, Mac Sarabhai etc. and they 
have more than 15 percent of budget for distributing the samples 
to the prospects. Samples are given mainly because of the 
following reasons; 
1. It provides an opportunity to the prospect to verify the 
claims made by the manufacturer in this literature. 
2. The samples are a constant reminder of the name of the 
product. 
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3. Samples itself works as a visual, 
4. It is customary to give samples, as now-a-days it is felt 
that if samples are not given, it hurts the feelings of 
the prospects. 
Samples allocations are done keeping in view the 
potential of the market and the budgetary allocations advanced 
by the organisations. 
Gifts Articles: 
Gift articles are generally given to establish the 
goodwill of the company among its prospects. They may also be 
given to enhance a particular product. Gifts articles are an 
effective re-inforcer since they are generally retained by the 
doctors and not passed on to any other person. Gift articles 
generally carry the name of the product and its USP, It is 
preferable that the items should be such that they may remain 
in constant view e.g. table items etc. This is so because the 
items to which the prospect is exposed acts as a constant 
reminder for him. In this constant professional items like 
tongue depressor, thermometer, stethescope, torch lights may be 
given. IDPL had also provided the torch 'lights as gift articles 
to all the retailers as a promotional programme. This has 
really increased the goodwill of the IDPL. 
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CONCLUSION 
In the end it can be concluded that the medical 
representative being a most effective tool of 'Sales Promotion' 
should develop a new habit of planning for creative selling 
through social contacts with doctors, pharmacists, nurses and 
other connected medical personnel. The importance of sound 
personal relationship between the doctors and the medical 
representatives to encourage the prescription of the drugs is 
surely pregnant with fruitful results. The success of the 
firms Sales Promotion equally depends upon the services 
provided by the medical profession. Medical representatives 
supplemented with other sales promotion tools and the different 
members of a single medical community are the two eyes through 
which we can visualise the success of the Sales Promotion 
strategy. 
Further/ it can be concluded that while advertising can 
pre-sell a product, sales promotion is the real sales clincher. 
Modern sales promotion techniques are more varied and complex. 
The aim of every competitive firm is to sell more and more to 
get ahead of the others. If we want not only to maintain but 
to progress further in this highly competitive, ridden with 
government controls field of pharmaceuticals, we should use 
all of the tools of sales promotion more effectively and 
efficiently. 
With the advancement of medical facilities and spread of 
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education with ever increasing population, more and more 
patients would need consultation and advices of the doctors, 
which would mean more potential prescription from the doctors 
to the chemists. One must, therefore take cognizance of the 
situation and derive maximum advantage- of the prescription 
potential by meeting the needs of the consumers in a well 
planned way. 
To sum up then, we can say that marketing is a battle 
half won through adequate promotional efforts. Sales Promotion 
being the crux of this industry. 
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